WO2017183539A1 - Method for producing bicyclic compound using meldrum's acid - Google Patents

Method for producing bicyclic compound using meldrum's acid Download PDF

Info

Publication number
WO2017183539A1
WO2017183539A1 PCT/JP2017/015019 JP2017015019W WO2017183539A1 WO 2017183539 A1 WO2017183539 A1 WO 2017183539A1 JP 2017015019 W JP2017015019 W JP 2017015019W WO 2017183539 A1 WO2017183539 A1 WO 2017183539A1
Authority
WO
WIPO (PCT)
Prior art keywords
group
compound
general formula
formula
base
Prior art date
Application number
PCT/JP2017/015019
Other languages
French (fr)
Japanese (ja)
Inventor
和利 鵜飼
友和 小倉
中山 敬司
Original Assignee
第一三共株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 第一三共株式会社 filed Critical 第一三共株式会社
Publication of WO2017183539A1 publication Critical patent/WO2017183539A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/45Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation
    • C07C45/48Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by condensation involving decarboxylation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/22Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from lactams, cyclic ketones or cyclic oximes, e.g. by reactions involving Beckmann rearrangement
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/32Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/385Saturated compounds containing a keto group being part of a ring
    • C07C49/417Saturated compounds containing a keto group being part of a ring polycyclic
    • C07C49/423Saturated compounds containing a keto group being part of a ring polycyclic a keto group being part of a condensed ring system
    • C07C49/427Saturated compounds containing a keto group being part of a ring polycyclic a keto group being part of a condensed ring system having two rings
    • C07C49/433Saturated compounds containing a keto group being part of a ring polycyclic a keto group being part of a condensed ring system having two rings the condensed ring system containing seven carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D319/00Heterocyclic compounds containing six-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D319/041,3-Dioxanes; Hydrogenated 1,3-dioxanes
    • C07D319/061,3-Dioxanes; Hydrogenated 1,3-dioxanes not condensed with other rings

Definitions

  • the present invention relates to a bicyclic ⁇ -amino acid derivative or a pharmacologically acceptable salt thereof, particularly a compound having activity as an ⁇ 2 ⁇ ligand and a method for producing an intermediate thereof.
  • Non-Patent Document 1 Compounds that show high affinity binding to the ⁇ 2 ⁇ subunit of voltage-gated calcium channels have been shown to be effective, for example, in the treatment of neuropathic pain (eg, Non-Patent Document 1 and Non-Patent Document 1). (See Patent Document 2).
  • ⁇ 2 ⁇ ligands are known as therapeutic agents for neuropathic pain, and examples of ⁇ 2 ⁇ ligands include gabapentin and pregabalin.
  • ⁇ 2 ⁇ ligands such as these compounds are useful for the treatment of epilepsy, neuropathic pain and the like (for example, Patent Document 1). Examples of other compounds are disclosed in Patent Document 2, Patent Document 3, Patent Document 4, and the like.
  • Patent Documents 7 and 8 are known as methods for synthesizing a compound having the formula (1) having a bicyclic ketone structure that is an intermediate for producing an ⁇ 2 ⁇ ligand.
  • Patent Document 7 From a compound having the formula (2) or the formula (3) via a compound having the formula (6) reacted with malonic acid, via a compound having the formula (7) obtained by decarboxylation, via a ketene derivative It has been reported that it is synthesized by the [2 + 2] reaction.
  • Patent Document 7 and Patent Document 8 From a compound having the formula (2) or the formula (3) via a compound having the formula (6) reacted with malonic acid, via a compound having the formula (7) obtained by decarboxylation, via a ketene derivative It has been reported that it is synthesized by the [2 + 2] reaction.
  • Patent Documents 5 and 6 report a method for producing a compound having the formula (1-6) as described in Scheme 1. That is, a compound having the formula (1-1) is reacted with a phosphonate to obtain a compound having the formula (1-2), and then reacted with nitromethane to obtain a compound having the formula (1-3). . Further, after reducing the nitro group of the compound having the formula (1-3), optical resolution is performed to obtain a compound having the formula (1-5), which is further hydrolyzed to have the formula (1-6) Have gained.
  • Ketene is an important reactive species used in various reactions.
  • the flow-type manufacturing technology flow synthesis
  • the present invention provides a methodology for efficiently producing a compound having the formula (1).
  • the compound having the formula (1) is a racemic mixture of the compound having the formula (1 ′) and the formula (1 ′′), but is described as a compound having the above formula (1) for convenience.
  • the present invention provides a compound having the formula (1), a compound having the general formula (4) produced from a compound having the formula (2) or the general formula (3), and further a compound having the general formula (4).
  • the present invention relates to a method for efficiently producing and providing using a derived compound having the general formula (5) or (5 ′).
  • R 1 and R 2 each independently represent a C1-C6 alkyl group, or R 1 and R 2 together with the same nitrogen atom to which they are attached a 4-6 membered saturated heterocyclyl group.
  • Show R 5 and R 6 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 5 and R 6 together with the nitrogen atom to which they are attached represents a heterocyclic group
  • R 7 represents a C1-C6 alkylcarbonyloxy group, a halogen atom, or a succinimide-N-oxy group
  • X represents a halogen atom
  • M represents a metal atom.
  • a compound having the general formula (4) is produced by reacting the compound having 3) with Meldrum's acid or a derivative thereof, and the compound having the general formula (4), and further having the general formula (4).
  • a compound having the general formula (5) or (5 ′) derived from the compound reacting at a high temperature with an appropriate base, or heating at a high temperature, the compound having the formula (1) which has led to the success of the present invention.
  • the compound having the general formula (4) can be hydrolyzed to produce the compound having the formula (1) by adding an appropriate reaction reagent via the compound having the formula (6).
  • the present inventors do not obtain a compound having the formula (1) through such a stepwise reaction, but directly add a suitable base to the compound having the general formula (4). We have succeeded in finding that a compound having the formula (1) can be obtained.
  • Purification is carried out by adding an appropriate post-treatment to the compound having the general formula (4) obtained by mixing an appropriate amount of the reactants and performing flow synthesis (defined later) in stages.
  • the present inventors have found a method by which a compound having the formula (1) can be efficiently produced by adding an appropriate base in an appropriate solvent to a compound having the general formula (4). That is, the present invention includes the inventions described below.
  • a compound having the general formula (4) or a base adduct thereof [1] A compound having the general formula (4) or a base adduct thereof.
  • R 3 and R 4 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 3 and R 4 together with the same carbon atom to which they are attached represent a 3-6 membered cycloalkyl ring.
  • R 3 is a methyl group, an ethyl group, or a propyl group
  • R 4 is a methyl group, an ethyl group, or a propyl group, or a compound having the general formula (4) according to [1] or a compound thereof Base adduct.
  • [Four] The compound having the general formula (4) according to [1] or a base adduct thereof, wherein R 3 is a methyl group and R 4 is a methyl group.
  • the solvent is N, N-dimethylacetamide or toluene
  • the base is any one selected from the group consisting of morpholine, N-methylpiperazine, N-ethylpiperazine, piperidine, pyrrolidine, [5]-[7 ] The manufacturing method of any one of. [9] The production method according to any one of [5]-[8] by flow synthesis.
  • R 1 and R 2 represent a C1-C6 alkyl group, or R 1 and R 2 together with the same nitrogen atom to which they are bonded represent a 4-6 membered saturated heterocyclyl group.
  • X represents a halogen atom
  • R 3 and R 4 have the same meaning as described above.
  • R 1 is an ethyl group, a propyl group, an isopropyl group, or an isobutyl group
  • R 2 is an ethyl group, a propyl group, an isopropyl group, or an isobutyl group
  • R 1 and R 2 are It is bonded to the same nitrogen atom and is piperidine or morpholine
  • R 3 is a methyl group, an ethyl group, or a propyl group
  • R 4 is a methyl group, an ethyl group, or a propyl group
  • Solvents are N, N-dimethylacetamide (DMAc), N, N-dimethylformamide (DMF), N-methylpyrrolidone (NMP), diglyme, sulfolane, xylene, propylene carbonate, benzonitrile, cyclohexanone, chlorobenzene, anisole, di- [16]-[18]
  • DMAc N, N-dimethylacetamide
  • DMF N-dimethylformamide
  • NMP N-methylpyrrolidone
  • diglyme diglyme
  • sulfolane sulfolane
  • xylene propylene carbonate
  • benzonitrile benzonitrile
  • cyclohexanone chlorobenzene
  • anisole di- [16]-[18]
  • the production method according to any one of [16] to [18], which is one or more selected from the group consisting of butyl ether, normal butyl acetate, methyl is
  • Base consists of potassium acetate, pyridine, diazabicycloundecene (DBU), triethylamine, potassium fluoride, 1,2,4-triazole, imidazole, pyrazole, 1,2,3-benzotriazole, N-hydroxysuccinimide
  • DBU diazabicycloundecene
  • Base consists of potassium acetate, pyridine, diazabicycloundecene (DBU), triethylamine, potassium fluoride, 1,2,4-triazole, imidazole, pyrazole, 1,2,3-benzotriazole, N-hydroxysuccinimide
  • R 3 and R 4 are as defined above, and R 5 and R 6 are each independently a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or a substituted group.
  • An aralkyl group which may be substituted, or R 5 and R 6 together with the nitrogen atom to which they are attached represent a heterocyclic group
  • R 7 represents a C1-C6 alkylcarbonyloxy group, a halogen atom, or a succinimide-N-oxy group
  • M represents a metal atom.
  • R 3 is a methyl group
  • R 4 is a methyl group
  • R 5 and R 6 are imidazolyl groups formed together with the nitrogen atoms to which they are bonded
  • R 7 is an acetoxy group or a fluorine atom.
  • M is potassium or sodium.
  • an important intermediate for producing a compound known to have an ⁇ 2 ⁇ ligand action can be synthesized efficiently and with high quality, which has a great industrial advantage.
  • R 3 and R 4 for compounds having general formula (4):
  • R 3 and R 4 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 3 and R 4 Together with the same carbon atom to which they are attached represent a 3-6 membered cycloalkyl ring.
  • C1-C6 alkyl group refers to a straight or branched alkyl group having 1 to 6 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec -Butyl, tert-butyl, pentyl, isopentyl, 2-methylbutyl, neopentyl, 1-ethylpropyl, hexyl, isohexyl, 4-methylpentyl, 3-methylpentyl, 2-methyl Pentyl group, 1-methylpentyl group, 3,3-dimethylbutyl group, 2,2-dimethylbutyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutyl group, 1,3-dimethylbutyl group, 2 , 3-dimethylbutyl group, 2-ethylbutyl group and the like.
  • R 3 and R 4 are preferably a methyl group, an ethyl group, or a propyl group, and more preferably a methyl group.
  • the “optionally substituted aryl group” means a C1-C6 alkyl group such as a methyl group or an ethyl group, a phenyl group which may be substituted with 1 to 3 groups such as a cyano group, a nitro group or a halogen atom, methyl Group, C1-C6 alkyl group such as ethyl group, cyano group, nitro group, naphthyl group optionally substituted by 1-3 halogen atoms, etc., preferably phenyl group.
  • the “optionally substituted aralkyl group” means a C1-C6 alkyl group such as a methyl group or an ethyl group, a benzyl group or a methyl group which may be substituted with a cyano group, a nitro group or a halogen atom.
  • a C1-C6 alkyl group such as an ethyl group, a cyano group, a nitro group, a naphthylmethyl group optionally substituted by 1-3 halogen atoms, and the like, and a benzyl group is preferred.
  • 3-6 membered cycloalkyl ring together with the same carbon atom to which they are attached is cyclopropane, cyclobutane, cyclopentane, cyclohexane, each ring being a C1-C6 alkyl group, cyano 1-3 may be substituted with a group, a nitro group, a halogen atom or the like.
  • Salt refers to a salt of a compound having an acidic group or basic group, which can be formed into an ion pair by reacting with a base or acid.
  • the “basic salt” is preferably an alkali metal salt such as sodium salt, potassium salt or lithium salt; an alkaline earth metal salt such as magnesium salt or calcium salt; N-methylmorpholine salt, triethylamine salt, Organic base salts such as tributylamine salt, diisopropylethylamine salt, dicyclohexylamine salt, N-methylpiperidine salt, pyridine salt, 4-pyrrolidinopyridine salt, picoline salt or glycine salt, lysine salt, arginine salt, ornithine salt, glutamic acid Amino acid salts such as salt and aspartate.
  • alkali metal salt such as sodium salt, potassium salt or lithium salt
  • an alkaline earth metal salt such as magnesium salt or calcium salt
  • N-methylmorpholine salt such as triethylamine salt
  • Organic base salts such as tributylamine salt, diisopropylethylamine salt, dicyclohexylamine salt, N
  • the “acid salt” preferably, hydrohalide such as hydrofluoride, hydrochloride, hydrobromide, hydroiodide, nitrate, perchlorate, sulfate, Inorganic acid salts such as phosphates; lower alkane sulfonates such as methane sulfonate, trifluoromethane sulfonate and ethane sulfonate, aryl sulfones such as benzene sulfonate and p-toluene sulfonate Acid salt, acetate salt, malate salt, fumarate salt, succinate salt, citrate salt, ascorbate salt, tartrate salt, succinate salt, maleate salt, etc .; and glycine salt, lysine salt , Amino acid salts such as arginine salt, ornithine salt, glutamate, aspartate.
  • hydrohalide such as hydrofluoride, hydrochloride, hydro
  • the compound of the present invention or a pharmacologically acceptable salt thereof may absorb moisture, adhere to adsorbed water, or become a hydrate when left in the air or by recrystallization.
  • the present invention also includes such various hydrates, solvates and polymorphic compounds.
  • the “base adduct” is referred to as a base adduct because, when the compound has a Lewis acidic group, a Lewis basic compound is appropriately reacted to form the added compound.
  • Lewis basic compounds include potassium acetate, pyridine, diazabicycloundecene (DBU), triethylamine, potassium fluoride, 1,2,4-triazole, imidazole, pyrazole, 1,2,3-benzotriazole, Examples thereof include N-hydroxysuccinimide.
  • These Lewis basic compounds can form base adducts with compounds such as, for example, ⁇ , ⁇ -unsaturated dicarbonyl compounds.
  • Tertiary amines also have Lewis basicity, and when they are added, they form quaternary ammoniums, but generate enol-type base adducts with intramolecular ion pairs in which anions are raised on oxygen atoms. Conceivable.
  • R 1 , R 2 and X for compounds having general formula (3):
  • R 1 and R 2 represent a C1-C6 alkyl group, or R 1 and R 2 together with the same nitrogen atom to which they are attached represent a 4-6 membered saturated heterocyclyl group, X represents a halogen atom.
  • the “C1-C6 alkyl group” has the same meaning as described above, and R 1 and R 2 are preferably an ethyl group, a propyl group, an isopropyl group, or an isobutyl group, and more preferably an isobutyl group. It is. “A 4-6 membered saturated heterocyclyl group together with the same nitrogen atom to which they are attached” is a 4-6 membered saturated cyclic group containing at least a carbon atom and one nitrogen atom. A saturated cyclic group which may contain one or more nitrogen atoms, oxygen atoms or sulfur atoms, and has a bond on the nitrogen atom.
  • the nitrogen atom having a bond is present as an iminium ion.
  • the saturated cyclic group containing at least a carbon atom and one nitrogen atom is an iminium ion such as an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, and each group is a C1-C6 alkyl group, a cyano group.
  • 1-3 may be substituted with a group, a nitro group, a halogen atom or the like.
  • Preferred is an iminium ion of a piperidinyl group.
  • a saturated cyclic group containing at least a carbon atom and one nitrogen atom and a saturated cyclic group containing one or more nitrogen atoms, oxygen atoms or sulfur atoms include morpholinyl group, piperazinyl
  • it is an iminium ion of a morpholinyl group.
  • halogen atom is a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.
  • R 3 , R 4 , R 5 , R 6 , R 7 and M for compounds having general formula (5) or (5 ′):
  • R 3 and R 4 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 3 and R 4 Together with the same carbon atom to which they are attached represents a 3-6 membered cycloalkyl ring
  • R 5 and R 6 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 5 and R 6 together with the nitrogen atom to which they are attached represents a heterocyclic group
  • R 7 represents a C1-C6 alkylcarbonyloxy group, a halogen atom, or a succinimide-N-oxy group
  • M represents a metal atom.
  • C1-C6 alkyl group has the same meaning as described above, but the “C1-C6 alkyl group” suitable as R 3 and R 4 is a methyl group.
  • the “optionally substituted aryl group” has the same meaning as described above.
  • the “optionally substituted aralkyl group” has the same meaning as described above. “3-6 membered cycloalkyl ring together with the same carbon atom to which they are attached” is as defined above.
  • Heterocyclic group together with the nitrogen atom to which they are attached means a saturated or unsaturated cyclic group in which one or more of the atoms forming the ring are a nitrogen atom and other hetero groups It includes a cyclic group containing an atom, and a plurality of cyclic groups are condensed. Specifically, there are groups as shown below.
  • the “C1-C6 alkylcarbonyloxy group” is a group in which a carbonyloxy group is bonded to a C1-C6 alkyl group, and preferably an acetoxy group.
  • the “halogen atom” has the same meaning as described above. Preferable is a fluorine atom.
  • the “metal atom” is an alkali metal such as sodium, potassium or lithium; an alkaline earth metal such as magnesium or calcium, and preferably an alkali metal.
  • the “meldrum acid derivative” means that malonic acid and R 3 and R 4 derived from various ketones are each independently a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or , An optionally substituted aralkyl group, or a compound in which R 3 and R 4 together with the same carbon atom to which they are attached form a 3-6 membered cycloalkyl ring.
  • Flow synthesis is a method in which a reaction is performed by passing through a tube reactor or the like in which necessary raw materials, reagents and the like are adjusted in temperature as a solution.
  • Tube reactor A tube with a thin system or a metal tube wrapped around it. The actual reaction is carried out in this.
  • Step A1 is a step in which a reaction is performed in a column reactor to produce acetal from alcohol and aldehyde.
  • the equivalent amount of reagent is theoretically equivalent to 1 equivalent, but in many ordinary reactions, no improvement in yield is observed.
  • the equivalents of all reagents can be obtained in a sufficiently high yield with one equivalent or a small excess.
  • the compound having the general formula (4) can be obtained in a sufficiently high yield by using one equivalent or a small excess of each reagent relative to normal butyraldehyde. Solvents that can be used in the reaction are more efficient for flow synthesis when the solvents are unified.
  • ether solvents such as tetrahydrofuran and 1,2-dimethoxyethane, methanol, ethanol, 2-propanol, etc.
  • Alcohol solvents such as toluene, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, aliphatic ester solvents such as ethyl acetate, or amide solvents such as N, N-dimethylacetamide and N, N-dimethylformamide
  • polar solvents such as acetonitrile and N, N-dimethylacetamide are suitable.
  • the reaction can be carried out smoothly without using a solvent.
  • the reaction temperature is preferably in the range of ⁇ 30 ° C. to 50 ° C., more preferably in the range of ⁇ 10 ° C. to 20 ° C.
  • the reaction time is usually 5-30 minutes.
  • Step A2 is a step for producing the compound having the formula (2) by reacting the acetal produced in Step A1 with an acid and an acid anhydride in a tube reactor.
  • the solvent that can be used for the reaction is the same solvent as Step A1.
  • a solvent such as N, N-dimethylacetamide (DMAc) can be added and the reaction can be performed at a concentration of about 2 mol / L.
  • the reaction temperature is preferably in the range of 120 ° C to 300 ° C, more preferably in the range of 180 ° C to 250 ° C.
  • the reaction time is usually 10-40 minutes. In a tube reactor, a pressure of about 5 bar is appropriate as a back pressure.
  • Step A3 is a step of producing a compound having the general formula (4) by reacting the compound having the formula (2) produced in Step A2 with Meldrum's acid or a derivative thereof in a tube reactor. Also in this step, about 1 equivalent of Meldrum's acid or its derivative may be used.
  • the solvent that can be used for the reaction is the same solvent as Step A1.
  • a solvent such as N, N-dimethylacetamide (DMAc) can be added and the reaction can be performed at a concentration of about 2 mol / L.
  • the reaction temperature is preferably in the range of 50 ° C to 100 ° C, more preferably 60 ° C to 80 ° C.
  • the reaction time is usually 10-30 minutes.
  • Solvents that can be used include ether solvents such as tetrahydrofuran and 1,2-dimethoxyethane, alcohol solvents such as methanol, ethanol, and 2-propanol, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, and acetic acid.
  • Aliphatic ester solvents such as ethyl or amide solvents such as N, N-dimethylacetamide and N, N-dimethylformamide are suitable, and polar solvents such as acetonitrile and N, N-dimethylacetamide are particularly suitable. It is.
  • the base that can be used is usually the base used, but is preferably morpholine.
  • the reaction temperature is usually preferably 20-40 ° C.
  • the reaction time is usually preferably about 30 minutes.
  • Step B1 is a step in which enamine is produced from amine and aldehyde by performing reaction in a column reactor.
  • the equivalent amount of the reagent used in synthesizing the compound having the general formula (4) is theoretically equivalent to 1 equivalent, but in many usual reactions, no improvement in yield is observed.
  • the equivalents of all reagents can be obtained in a sufficiently high yield with one equivalent or a small excess.
  • the compound having the general formula (4) can be obtained in a sufficiently high yield by using one equivalent or a small excess of each reagent relative to normal butyraldehyde. Solvents that can be used in the reaction are more efficient for flow synthesis when the solvents are unified.
  • ether solvents such as tetrahydrofuran and 1,2-dimethoxyethane, methanol, ethanol, 2-propanol, etc.
  • Alcohol solvents such as toluene, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, aliphatic ester solvents such as ethyl acetate, or amide solvents such as N, N-dimethylacetamide and N, N-dimethylformamide
  • polar solvents such as acetonitrile and N, N-dimethylacetamide are suitable.
  • the reaction can be carried out smoothly without using a solvent.
  • the reaction temperature is preferably in the range of ⁇ 30 ° C. to 50 ° C., and more preferably near room temperature.
  • the reaction time is usually 5-30 minutes.
  • a pressure of about 40 psi is appropriate as the back pressure.
  • Step B2 is a step in which the enamine produced in Step B1 is reacted with allyl halide in a tube reactor to produce a compound having the general formula (3). Also in this step, about 1 equivalent of allyl halide may be used.
  • the solvent that can be used for the reaction is the same solvent as Step B1.
  • Step B2 for example, a solvent such as acetonitrile (MeCN) or N, N-dimethylacetamide (DMAc) can be added and the reaction can be performed at a concentration of about 2 mol / L.
  • the reaction temperature is preferably in the range of 60 ° C to 180 ° C, more preferably in the range of 100 ° C to 150 ° C.
  • the reaction time is usually 30-40 minutes.
  • a pressure of about 100 psi is appropriate as a back pressure.
  • Step B3 is a step of producing a compound having the general formula (4) by reacting the compound having the general formula (3) generated in Step B2 with Meldrum's acid or a derivative thereof in a tube reactor. Also in this step, about 1 equivalent of Meldrum's acid or its derivative may be used.
  • the solvent that can be used for the reaction is the same solvent as Step B1.
  • a solvent such as N, N-dimethylacetamide (DMAc) can be added and the reaction can be performed at a concentration of about 0.5 mol / L.
  • the reaction temperature is preferably in the range of 50 ° C to 100 ° C, more preferably 60 ° C to 80 ° C.
  • the reaction time is usually 10-15 minutes.
  • a compound having the formula (1) is obtained by adding a base to a solution of the compound having the general formula (4) and then heating.
  • Solvents that can be used are N, N-dimethylacetamide (DMAc), N, N-dimethylformamide (DMF), N-methylpyrrolidone (NMP), diglyme, sulfolane, xylene, propylene carbonate, benzonitrile, cyclohexanone, chlorobenzene, Anisole, dibutyl ether, normal butyl acetate, methyl isobutyl ketone and acetophenone are preferred, and N, N-dimethylacetamide (DMAc) is preferred.
  • Bases that can be used are preferably potassium acetate, pyridine, diazabicycloundecene (DBU), triethylamine, potassium fluoride, 1,2,4-triazole, imidazole, pyrazole, 1,2,3-benzotriazole N-hydroxysuccinimide, more preferably imidazole.
  • the reaction temperature is usually preferably 120-220 ° C, more preferably 120 ° C.
  • the reaction time is usually preferably 10 minutes to 48 hours, more preferably 15 hours.
  • the reaction time can be shortened by using microwaves and heating.
  • the microwave that can be used is usually preferably 5-150 W, and more preferably 150 W.
  • Step4-1 Step of hydrolyzing (and partially decarboxylating) a compound having the general formula (4) to form a compound having the formula (6)
  • N N-dimethyl is used as a solvent in the presence of water.
  • DMAc acetamide
  • Step4-2 A step of heating a compound having formula (6) (including a partially decarboxylated compound) to form a compound having formula (1).
  • Step 5-1 Step of obtaining a compound having the general formula (5) or (5 ′)
  • Bases that can be used are an amine, primary amines, secondary amines, tertiary amines and the like are considered. Particularly suitable are amines such as benzylamine for primary amines, morpholine, pyrrolidine, piperidine, imidazole, etc. for secondary amines, and diazabicycloundecene (DBU) for tertiary amines and 1 , 4-diazabicyclo [2.2.2] octane (DABCO) and the like.
  • DBU diazabicycloundecene
  • an alkali metal or alkaline earth metal salt of a C2-C6 alkyl carboxylic acid is preferable, and examples thereof include sodium acetate and potassium acetate.
  • the base used is an inorganic base, it may be a base having an alkali metal or an alkaline earth metal, an alkali metal salt of a carboxylic acid, an alkaline earth metal salt, an alkali metal salt of an alcohol or an alkaline earth metal Salt is good.
  • the equivalent of the base to be used varies depending on the kind of the base to be used, but usually the equivalent of the base to be added is preferably in the range of 0.5 to 3 equivalents, particularly preferably in the range of 0.9 to 1.5 equivalents.
  • Solvents that can be used include ether solvents such as tetrahydrofuran and 1,2-dimethoxyethane, alcohol solvents such as methanol, ethanol, and 2-propanol, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, and acetic acid.
  • Aliphatic ester solvents such as ethyl or amide solvents such as N, N-dimethylacetamide and N, N-dimethylformamide are suitable, and polar solvents such as acetonitrile and N, N-dimethylacetamide are particularly good.
  • the reaction temperature can be any temperature as long as it is within the boiling point of the solvent, and is preferably carried out at around room temperature.
  • the reaction time is usually preferably 5 minutes to 2 hours.
  • Step 5-2 Step of obtaining a compound having the formula (1)
  • the solvents that can be used are the same as those that can be used in Step C1.
  • the reaction temperature is in the range of 100 ° C. to 300 ° C., and particularly preferably in the range of 120 ° C. to 250 ° C.
  • the reaction time is usually preferably 10 minutes to 48 hours.
  • the compound having the general formula (4) is passed through the compound having the general formula (5) or (5 ′), followed by heating to obtain the formula (1).
  • a method for obtaining a compound having the above will be described.
  • Step C1 is a step of treating a compound having the general formula (4) with a base to produce a compound having the general formula (5) which is a base adduct.
  • a base for producing a base adduct from a compound having the general formula (4) that is, as a base for obtaining a compound having the general formula (5), a primary amine having a normal alkyl or aralkyl group, An aromatic primary amine, a secondary amine having an alkyl group, an araalkyl group, or the like, or an aromatic secondary amine, further a tertiary amine having an alkyl group or an aralkyl group, or an aromatic tertiary amine is preferable.
  • the base adduct refers to a reaction adduct of a Michael addition acceptor with a nucleophilic Lewis base.
  • the base used is an amine
  • an amine such as benzylamine is preferable for a primary amine
  • morpholine, pyrrolidine, piperidine, imidazole, or the like is preferable for a secondary amine.
  • the base used is an organic acid base
  • an alkali metal salt or alkaline earth metal salt of a C2-C6 alkylcarboxylic acid is preferable, and examples thereof include sodium acetate and potassium acetate.
  • the base used is an inorganic base, it may be a Lewis base capable of Michael addition, and may be a base having an alkali metal or an alkaline earth metal, such as potassium fluoride.
  • the equivalent of the base to be used varies depending on the kind of the base to be used, but usually the equivalent of the base to be added is preferably in the range of 0.5 to 3 equivalents, particularly preferably in the range of 0.9 to 1.5 equivalents.
  • the equivalent amount of the reagent used in synthesizing the compound having the general formula (5) is theoretically equivalent to 1 equivalent, but in many reactions, no improvement in yield is observed.
  • the compound having the general formula (5) can be obtained in a sufficiently high yield with the equivalent amount of all reagents being one equivalent or a small excess.
  • Solvents that can be used include ethers such as tetrahydrofuran and 1,2-dimethoxyethane, alcohols such as methanol, ethanol and 2-propanol, hydrocarbons such as toluene, nitriles such as acetonitrile, and acetic acid.
  • Aliphatic ester solvents such as ethyl or amide solvents such as N, N-dimethylacetamide and N, N-dimethylformamide are suitable, and polar solvents such as acetonitrile and N, N-dimethylacetamide are particularly good.
  • the reaction temperature can be any temperature as long as it is within the boiling point of the solvent, and is preferably carried out at around room temperature.
  • the reaction time is usually about 5 minutes to 2 hours.
  • Step C2 is a step of heating the compound having the general formula (5) to generate the compound having the formula (1).
  • Solvents that can be used are the same as those that can be used in Step C1.
  • the reaction temperature is in the range of 100 ° C. to 300 ° C., and particularly preferably in the range of 120 ° C. to 250 ° C.
  • the bases to be added to the compound having the general formula (4) include imidazole and sodium acetate among the above-mentioned bases. Or potassium acetate is good.
  • the solvent includes ethers such as tetrahydrofuran, 1,2-dimethoxyethane, diglyme, methanol, ethanol, 2- Alcohol solvents such as propanol, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, aliphatic ester solvents such as ethyl acetate, or amides such as N, N-dimethylacetamide and N, N-dimethylformamide Suitable solvents are, for example, polar solvents such as acetonitrile and N, N-dimethylacetamide, and ether solvents such as diglyme.
  • ethers such as tetrahydrofuran, 1,2-dimethoxyethane, diglyme, methanol, ethanol, 2- Alcohol solvents such as propanol, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, aliphatic ester solvents such as ethy
  • the reaction temperature is in the range of 100 ° C. to 300 ° C., and particularly in the range of 120 ° C. to 250 ° C.
  • Example 1 5- (2-Ethylpent-4-en-1-ylidene) -2,2-dimethyl-1,3-dioxane-4,6-dione (4 ') (Example 1-1) Compound (2) to Compound (4 ') (batch reaction)
  • the flow device was installed as described above. Feed A with diisobutylamine, Feed B with butyraldehyde, Feed C with DMAc solution of allyl bromide (24.20 g, 200 mmol) (100 mL, 2.0 M in total), Feed D with Meldrum acid (14.41 g, 100 mmol), morpholine (875 ⁇ L, 10.0 mmol) of DMAc solution (total 200 mL, 0.5 M against Meldrum's acid) was prepared.
  • a reactor (15 mm id, 30 cm), a tube reactor heated to 120 ° C. (16 mL), and a tube reactor heated to 60 ° C. (10 mL ⁇ 2) were passed through.
  • the solution obtained by continuous operation for 5 hours contained 26.79 g of the title compound (UPLC® quantitative value, yield 62%).
  • Example 1-2 To the DMAc solution obtained in Example 1-2 in which the compound (4 ′) was dissolved, toluene (5 mL), water (5 mL), 5% (w / w) sodium bicarbonate water (2 mL) were added, Liquid separation was performed. The aqueous layer was re-extracted with toluene (2 mL). The obtained organic layers were matched, and liquid separation washing was repeated twice with 5% (w / w) sodium bicarbonate water (2 mL). Thereafter, the mixture was washed with 0.5N hydrochloric acid (2 mL) and separated with water (2 mL).

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

[Problem] To provide a compound that can be used on an industrial scale. [Solution] A compound represented by general formula (4) or a base adduct thereof. (In the formula, R3 and R4 independently represent a hydrogen atom or the like.)

Description

メルドラム酸を用いる二環性化合物の製造方法Method for producing bicyclic compound using Meldrum's acid
 本発明は、二環性γ-アミノ酸誘導体又はその薬理学的に許容される塩、特に、α2δリガンドとして活性を有する化合物及びその中間体の製造方法に関する。 The present invention relates to a bicyclic γ-amino acid derivative or a pharmacologically acceptable salt thereof, particularly a compound having activity as an α 2 δ ligand and a method for producing an intermediate thereof.
 電位依存性カルシウムチャネルのα2δサブユニットに対して高親和性結合を示す化合物は、例えば神経因性疼痛の治療において有効であることが明らかになっている(例えば、非特許文献1および非特許文献2参照)。 Compounds that show high affinity binding to the α 2 δ subunit of voltage-gated calcium channels have been shown to be effective, for example, in the treatment of neuropathic pain (eg, Non-Patent Document 1 and Non-Patent Document 1). (See Patent Document 2).
 これまでに、神経因性疼痛の治療薬として数種類のα2δリガンドが知られており、α2δリガンドとしては、例えば、ガバペンチン、プレガバリンなどがある。これらの化合物のようなα2δリガンドは、てんかんおよび神経因性疼痛等の治療に有用である(例えば、特許文献1)。その他の化合物としては、例えば、特許文献2、特許文献3、特許文献4などに開示されている。
 また、出願人は、これまでにα2δリガンド及びその製造方法として、特許文献5-8等を報告している。
 α2δリガンドの製造中間体となる二環性ケトン構造を有する式(1)を有する化合物の合成法としては、特許文献7及び特許文献8が知られている。式(2)や式(3)を有する化合物からマロン酸と反応した式(6)を有する化合物を経て、脱炭酸をして得られる式(7)を有する化合物を経由し、ケテン誘導体を経由して[2+2]反応により合成されることが報告されている。(特許文献7及び特許文献8)
So far, several types of α 2 δ ligands are known as therapeutic agents for neuropathic pain, and examples of α 2 δ ligands include gabapentin and pregabalin. Α 2 δ ligands such as these compounds are useful for the treatment of epilepsy, neuropathic pain and the like (for example, Patent Document 1). Examples of other compounds are disclosed in Patent Document 2, Patent Document 3, Patent Document 4, and the like.
In addition, the applicant has previously reported Patent Documents 5-8 and the like as α 2 δ ligands and production methods thereof.
Patent Documents 7 and 8 are known as methods for synthesizing a compound having the formula (1) having a bicyclic ketone structure that is an intermediate for producing an α 2 δ ligand. From a compound having the formula (2) or the formula (3) via a compound having the formula (6) reacted with malonic acid, via a compound having the formula (7) obtained by decarboxylation, via a ketene derivative It has been reported that it is synthesized by the [2 + 2] reaction. (Patent Document 7 and Patent Document 8)
Figure JPOXMLDOC01-appb-C000009
Figure JPOXMLDOC01-appb-C000009
 特許文献5及び特許文献6には、Scheme 1に記載のような式(1-6)を有する化合物の製造方法が報告されている。すなわち式(1-1)を有する化合物を、ホスホン酸エステルと反応させて、式(1-2)を有する化合物とした後、ニトロメタンと反応させて、式(1-3)を有する化合物とする。さらに、式(1-3)を有する化合物のニトロ基を還元した後に、光学分割を行って式(1-5)を有する化合物とし、さらに、加水分解して式(1-6)を有する化合物を得ている。 Patent Documents 5 and 6 report a method for producing a compound having the formula (1-6) as described in Scheme 1. That is, a compound having the formula (1-1) is reacted with a phosphonate to obtain a compound having the formula (1-2), and then reacted with nitromethane to obtain a compound having the formula (1-3). . Further, after reducing the nitro group of the compound having the formula (1-3), optical resolution is performed to obtain a compound having the formula (1-5), which is further hydrolyzed to have the formula (1-6) Have gained.
Figure JPOXMLDOC01-appb-C000010
Figure JPOXMLDOC01-appb-C000010
 メルドラム酸誘導体は超高温で分解し、アセトンと二酸化炭素を発生しながらケテンを生成することが知られている(例えば、非特許文献3)。ケテンは種々の反応に用いられる重要反応活性種である。
 また、フロー式製造技術(フロー合成)は、反応時間の短縮並びに溶媒の沸点以上の反応が容易に行われる、あるいは、すぐに反応目的温度に達し、すぐに安定な温度へと変換できること等から、反応物、生成物の安定性を欠く化合物の反応に向いているとされている(例えば、非特許文献4)。
Meldrum's acid derivatives are known to decompose at ultra-high temperatures to produce ketene while generating acetone and carbon dioxide (eg, Non-Patent Document 3). Ketene is an important reactive species used in various reactions.
In addition, the flow-type manufacturing technology (flow synthesis) can shorten the reaction time and facilitate the reaction above the boiling point of the solvent, or it can quickly reach the target reaction temperature and immediately convert it to a stable temperature. It is said that it is suitable for reaction of a compound lacking stability of reactants and products (for example, Non-Patent Document 4).
US 2006/154929US 2006/154929 US 2003/220397US 2003/220397 US 2004/152779US 2004/152779 US 2003/78300US 2003/78300 US 2010/249229US 2010/249229 US 2012/071685US 2012/071685 US 2014/094624US 2014/094624 US 2014/094623US 2014/094623
 本発明は、式(1)を有する化合物を効率的に製造するための方法論を提供するものである。 The present invention provides a methodology for efficiently producing a compound having the formula (1).
Figure JPOXMLDOC01-appb-C000011
Figure JPOXMLDOC01-appb-C000011
(式(1)を有する化合物は、式(1’)と式(1’’)を有する化合物とのラセミ混合物であるが、便宜上、上記式(1)を有する化合物のように記載する。)
 本発明は、式(1)を有する化合物を、式(2)又は一般式(3)を有する化合物から製造される一般式(4)を有する化合物、さらには一般式(4)を有する化合物より誘導される一般式(5)又は(5’)を有する化合物を用いて、効率的に製造し提供する方法に関するものである。
(The compound having the formula (1) is a racemic mixture of the compound having the formula (1 ′) and the formula (1 ″), but is described as a compound having the above formula (1) for convenience.)
The present invention provides a compound having the formula (1), a compound having the general formula (4) produced from a compound having the formula (2) or the general formula (3), and further a compound having the general formula (4). The present invention relates to a method for efficiently producing and providing using a derived compound having the general formula (5) or (5 ′).
Figure JPOXMLDOC01-appb-C000012
Figure JPOXMLDOC01-appb-C000012
(式中、
R1及びR2は、それぞれ独立して、C1-C6アルキル基を示し、又は、R1及びR2が、それらが結合する同一の窒素原子と一緒になって4-6員飽和ヘテロシクリル基を示し、
R5及びR6は、それぞれ独立して、水素原子、C1-C6アルキル基、置換されていてもよいアリール基を示し、又は、置換されていてもよいアラルキル基を示し、或いは、R5及びR6がそれらが結合する窒素原子と一緒になって複素環基を示し、
R7は、C1-C6アルキルカルボニルオキシ基、ハロゲン原子、又は、スクシンイミド-N-オキシ基を示し、
Xはハロゲン原子を示し、
Mは金属原子を示す。)
(Where
R 1 and R 2 each independently represent a C1-C6 alkyl group, or R 1 and R 2 together with the same nitrogen atom to which they are attached a 4-6 membered saturated heterocyclyl group. Show
R 5 and R 6 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 5 and R 6 together with the nitrogen atom to which they are attached represents a heterocyclic group,
R 7 represents a C1-C6 alkylcarbonyloxy group, a halogen atom, or a succinimide-N-oxy group,
X represents a halogen atom,
M represents a metal atom. )
 本発明者らは、鋭意検討した結果、以下に説明するように課題を解決して、式(1)を有する化合物を提供するにあたり、効率的に合成を実施した式(2)又は一般式(3)を有する化合物に対して、メルドラム酸又はその誘導体を作用させることにより一般式(4)を有する化合物を製造し、その一般式(4)を有する化合物、さらには一般式(4)を有する化合物より誘導される一般式(5)又は(5’)を有する化合物を用いて、適切な塩基を用い高温にて反応させる、あるいは高温にて加熱を行うことにより式(1)を有する化合物を合成し、本発明を成功させるに至った。 As a result of intensive studies, the inventors solved the problem as described below, and provided a compound having the formula (1), the formula (2) or the general formula ( A compound having the general formula (4) is produced by reacting the compound having 3) with Meldrum's acid or a derivative thereof, and the compound having the general formula (4), and further having the general formula (4). Using a compound having the general formula (5) or (5 ′) derived from the compound, reacting at a high temperature with an appropriate base, or heating at a high temperature, the compound having the formula (1) Which has led to the success of the present invention.
 式(2)又は一般式(3)を有する化合物と、メルドラム酸又はその誘導体との縮合反応において、使用する化合物、縮合反応の反応時間、反応条件等を研究した結果、無駄な反応剤を使用しない組み合わせを見出すことに成功し、一般式(4)を有する化合物を効率的に合成することに成功した。 In the condensation reaction between the compound having the formula (2) or the general formula (3) and meldrum acid or a derivative thereof, as a result of studying the compound to be used, the reaction time of the condensation reaction, the reaction conditions, etc., useless reagents are used. And succeeded in efficiently synthesizing a compound having the general formula (4).
Figure JPOXMLDOC01-appb-C000013
Figure JPOXMLDOC01-appb-C000013
(式中の各記号は、上記と同様。) (Each symbol in the formula is the same as above.)
 一般式(4)を有する化合物は加水分解を行うことにより、式(6)を有する化合物を経て適切な反応試薬を追加することにより式(1)を有する化合物を製造することが出来る。一方で、本発明者らはこのような段階的反応を経て式(1)を有する化合物を得るのではなく、一般式(4)を有する化合物に、適切な塩基を加えることにより、直接的に式(1)を有する化合物が得られることを見出すことに成功した。 The compound having the general formula (4) can be hydrolyzed to produce the compound having the formula (1) by adding an appropriate reaction reagent via the compound having the formula (6). On the other hand, the present inventors do not obtain a compound having the formula (1) through such a stepwise reaction, but directly add a suitable base to the compound having the general formula (4). We have succeeded in finding that a compound having the formula (1) can be obtained.
Figure JPOXMLDOC01-appb-C000014
Figure JPOXMLDOC01-appb-C000014
(式中の各記号は、上記と同様。) (Each symbol in the formula is the same as above.)
 一般式(4)を有する化合物に適切な塩基を加えることによりその塩基付加体を結晶として一般式(5)又は(5’)を有する化合物を取得することにより、カラムクロマトグラフィ等による煩雑な精製法を回避したシンプルな精製法を開発し、高純度の式(1)を有する化合物を得ることに成功した。 By adding an appropriate base to the compound having the general formula (4) to obtain the compound having the general formula (5) or (5 ′) as a crystal of the base adduct, a complicated purification method such as column chromatography We have developed a simple purification method that avoids the above and succeeded in obtaining a compound having the high purity formula (1).
Figure JPOXMLDOC01-appb-C000015
Figure JPOXMLDOC01-appb-C000015
(式中の各記号は、上記と同様。) (Each symbol in the formula is the same as above.)
 一般式(5)又は(5’)を有する化合物は、加熱するだけで式(1)を有する化合物を与えることを見出した。 It has been found that a compound having the general formula (5) or (5 ') gives a compound having the formula (1) only by heating.
 反応剤を適切な量混ぜ、段階的にフロー合成(後記定義)を実施していくことによって得られる一般式(4)を有する化合物に、適切な後処理を加えることにより精製を実施し、その後一般式(4)を有する化合物に、適切な溶媒中で適切な塩基を添加させることにより式(1)を有する化合物を効率的に製造できる方法を見出した。
すなわち、本発明は以下に記載の発明を包含する。
Purification is carried out by adding an appropriate post-treatment to the compound having the general formula (4) obtained by mixing an appropriate amount of the reactants and performing flow synthesis (defined later) in stages. The present inventors have found a method by which a compound having the formula (1) can be efficiently produced by adding an appropriate base in an appropriate solvent to a compound having the general formula (4).
That is, the present invention includes the inventions described below.
[1]
 一般式(4)を有する化合物又はその塩基付加体。
[1]
A compound having the general formula (4) or a base adduct thereof.
Figure JPOXMLDOC01-appb-C000016
Figure JPOXMLDOC01-appb-C000016
(式中、R3及びR4は、それぞれ独立して、水素原子、C1-C6アルキル基、置換されていてもよいアリール基、又は、置換されていてもよいアラルキル基を示し、又は、R3及びR4がそれらが結合する同一の炭素原子と一緒になって3-6員のシクロアルキル環を示す。)
[2]
 [1]に記載の一般式(4)を有する化合物。
[3]
 R3が、メチル基、エチル基、又は、プロピル基であり、R4が、メチル基、エチル基、又は、プロピル基である、[1]に記載の一般式(4)を有する化合物又はその塩基付加体。
[4]
 R3が、メチル基であり、R4が、メチル基である、[1]に記載の一般式(4)を有する化合物又はその塩基付加体。
(Wherein R 3 and R 4 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 3 and R 4 together with the same carbon atom to which they are attached represent a 3-6 membered cycloalkyl ring.)
[2]
The compound having the general formula (4) according to [1].
[3]
R 3 is a methyl group, an ethyl group, or a propyl group, and R 4 is a methyl group, an ethyl group, or a propyl group, or a compound having the general formula (4) according to [1] or a compound thereof Base adduct.
[Four]
The compound having the general formula (4) according to [1] or a base adduct thereof, wherein R 3 is a methyl group and R 4 is a methyl group.
[5]
 溶媒、塩基の存在下、式(2)を有する化合物と、メルドラム酸又はその誘導体を用いる[1]に記載の一般式(4)を有する化合物又はその塩基付加体の製造方法。
[Five]
A method for producing a compound having the general formula (4) or a base adduct thereof according to [1], wherein the compound having the formula (2) and Meldrum's acid or a derivative thereof are used in the presence of a solvent and a base.
Figure JPOXMLDOC01-appb-C000017
Figure JPOXMLDOC01-appb-C000017
(式中、R3及びR4は、上述と同義を示す。)
[6]
 R3が、メチル基、エチル基、又は、プロピル基であり、R4が、メチル基、エチル基、又は、プロピル基である、[5]に記載の製造方法。
[7]
 R3が、メチル基であり、R4が、メチル基である、[5]に記載の製造方法。
[8]
 溶媒が、N,N-ジメチルアセトアミド又はトルエンであり、塩基が、モルホリン、N-メチルピペラジン、N-エチルピペラジン、ピペリジン、ピロリジンからなる群より選択されるいずれかである、[5]-[7]のいずれか1項に記載の製造方法。
[9]
 フロー合成による、[5]-[8]のいずれか1項に記載の製造方法。
(Wherein R 3 and R 4 have the same meaning as described above.)
[6]
The production method according to [5], wherein R 3 is a methyl group, an ethyl group, or a propyl group, and R 4 is a methyl group, an ethyl group, or a propyl group.
[7]
The production method according to [5], wherein R 3 is a methyl group, and R 4 is a methyl group.
[8]
The solvent is N, N-dimethylacetamide or toluene, and the base is any one selected from the group consisting of morpholine, N-methylpiperazine, N-ethylpiperazine, piperidine, pyrrolidine, [5]-[7 ] The manufacturing method of any one of.
[9]
The production method according to any one of [5]-[8] by flow synthesis.
[10]
 溶媒、塩基の存在下、一般式(3)を有する化合物と、メルドラム酸又はその誘導体を用いる[1]に記載の一般式(4)を有する化合物又はその塩基付加体の製造方法。
[Ten]
A process for producing a compound having the general formula (4) or a base adduct thereof according to [1] using a compound having the general formula (3) and Meldrum's acid or a derivative thereof in the presence of a solvent or a base.
Figure JPOXMLDOC01-appb-C000018
Figure JPOXMLDOC01-appb-C000018
(式中、R1及びR2は、C1-C6アルキル基を示し、又は、R1及びR2が、それらが結合する同一の窒素原子と一緒になって4-6員飽和ヘテロシクリル基を示し、Xは、ハロゲン原子を示し、R3及びR4は、上述と同義を示す。)
[11]
 R1が、エチル基、プロピル基、イソプロピル基、又は、イソブチル基であり、R2が、エチル基、プロピル基又は、イソプロピル基、又は、イソブチル基であり、又は、R1とR2が、同一の窒素原子に結合して、ピペリジン又はモルホリンであり、R3が、メチル基、エチル基、又は、プロピル基であり、R4が、メチル基、エチル基、又は、プロピル基である、[10]に記載の製造方法。
[12]
 R1が、イソブチル基であり、R2が、イソブチル基であり、R3が、メチル基であり、R4が、メチル基である、[10]に記載の製造方法。
[13]
 溶媒が、N,N-ジメチルアセトアミド又はアセトニトリルである、[10]-[12]のいずれか1項に記載の製造方法。
[14]
 塩基が、モルホリンである、[10]-[13]のいずれか1項に記載の製造方法。
[15]
 フロー合成による、[10]-[14]のいずれか1項に記載の製造方法。
(Wherein R 1 and R 2 represent a C1-C6 alkyl group, or R 1 and R 2 together with the same nitrogen atom to which they are bonded represent a 4-6 membered saturated heterocyclyl group. X represents a halogen atom, and R 3 and R 4 have the same meaning as described above.)
[11]
R 1 is an ethyl group, a propyl group, an isopropyl group, or an isobutyl group, R 2 is an ethyl group, a propyl group, an isopropyl group, or an isobutyl group, or R 1 and R 2 are It is bonded to the same nitrogen atom and is piperidine or morpholine, R 3 is a methyl group, an ethyl group, or a propyl group, and R 4 is a methyl group, an ethyl group, or a propyl group, [10] The production method according to [10].
[12]
The production method according to [10], wherein R 1 is an isobutyl group, R 2 is an isobutyl group, R 3 is a methyl group, and R 4 is a methyl group.
[13]
[10] The production method according to any one of [10] to [12], wherein the solvent is N, N-dimethylacetamide or acetonitrile.
[14]
The production method according to any one of [10] to [13], wherein the base is morpholine.
[15]
[10] The production method according to any one of [10] to [14], which is performed by flow synthesis.
[16]
 溶媒、塩基の存在下、[1]に記載の一般式(4)を有する化合物又はその塩基付加体を用いる式(1)を有する化合物の製造方法。
[16]
A process for producing a compound having the formula (1) using the compound having the general formula (4) according to [1] or a base adduct thereof in the presence of a solvent and a base.
Figure JPOXMLDOC01-appb-C000019
Figure JPOXMLDOC01-appb-C000019
(式中、R3及びR4は、上述と同義を示す。)
[17]
 R3が、メチル基、エチル基、又は、プロピル基であり、R4が、メチル基、エチル基、又は、プロピル基である、[16]に記載の製造方法。
[18]
 R3が、メチル基であり、R4が、メチル基である、[16]に記載の製造方法。
[19]
 溶媒が、N,N-ジメチルアセトアミド(DMAc)、N,N-ジメチルホルムアミド(DMF)、N-メチルピロリドン(NMP)、ジグリム、スルホラン、キシレン、プロピレンカーボネート、ベンゾニトリル、シクロヘキサノン、クロロベンゼン、アニソール、ジブチルエーテル、酢酸ノルマルブチル、メチルイソブチルケトン、アセトフェノンからなる群より選択されるいずれか1種又は2種以上である、[16]-[18]のいずれか1項に記載の製造方法。
[20]
 塩基が、酢酸カリウム、ピリジン、ジアザビシクロウンデセン(DBU)、トリエチルアミン、フッ化カリウム、1,2,4-トリアゾール、イミダゾール、ピラゾール、1,2,3-ベンゾトリアゾール、N-ヒドロキシスクシンイミドからなる群より選択されるいずれか1種である、[16]-[19]のいずれか1項に記載の製造方法。
[21]
 フロー合成による、[16]-[20]のいずれか1項に記載の製造方法。
(Wherein R 3 and R 4 have the same meaning as described above.)
[17]
The production method according to [16], wherein R 3 is a methyl group, an ethyl group, or a propyl group, and R 4 is a methyl group, an ethyl group, or a propyl group.
[18]
The production method according to [16], wherein R 3 is a methyl group, and R 4 is a methyl group.
[19]
Solvents are N, N-dimethylacetamide (DMAc), N, N-dimethylformamide (DMF), N-methylpyrrolidone (NMP), diglyme, sulfolane, xylene, propylene carbonate, benzonitrile, cyclohexanone, chlorobenzene, anisole, di- [16]-[18] The production method according to any one of [16] to [18], which is one or more selected from the group consisting of butyl ether, normal butyl acetate, methyl isobutyl ketone, and acetophenone.
[20]
Base consists of potassium acetate, pyridine, diazabicycloundecene (DBU), triethylamine, potassium fluoride, 1,2,4-triazole, imidazole, pyrazole, 1,2,3-benzotriazole, N-hydroxysuccinimide [16] The production method according to any one of [16] to [19], which is any one selected from the group.
[twenty one]
[16] The production method according to any one of [16] to [20] by flow synthesis.
[22]
 [1]に記載の一般式(4)を有する化合物又はその塩基付加体を用いて、加水分解により一般式(6)を有する化合物又はその塩を得る工程を経る、式(1)を有する化合物の製造方法。
[twenty two]
A compound having the formula (1) which undergoes a step of obtaining a compound having the general formula (6) or a salt thereof by hydrolysis using the compound having the general formula (4) or the base adduct thereof according to [1] Manufacturing method.
Figure JPOXMLDOC01-appb-C000020
Figure JPOXMLDOC01-appb-C000020
(式中、R3及びR4は、上述と同義を示す。)
[23]
 フロー合成による、[22]に記載の製造方法。
(Wherein R 3 and R 4 have the same meaning as described above.)
[twenty three]
[22] The production method according to [22].
[24]
 溶媒、塩基の存在下、[1]に記載の一般式(4)を有する化合物を用いて、一般式(5)又は(5’)を有する化合物を得た後、加熱することによる、式(1)を有する化合物の製造方法。
[twenty four]
Using a compound having the general formula (4) described in [1] in the presence of a solvent or a base, a compound having the general formula (5) or (5 ′) is obtained, followed by heating to obtain the formula ( A method for producing a compound having 1).
Figure JPOXMLDOC01-appb-C000021
Figure JPOXMLDOC01-appb-C000021
(式中、R3及びR4は、上述と同義を示し、R5及びR6は、それぞれ独立して、水素原子、C1-C6アルキル基、置換されていてもよいアリール基、又は、置換されていてもよいアラルキル基を示し、又は、R5及びR6がそれらが結合する窒素原子と一緒になって複素環基を示し、
R7は、C1-C6アルキルカルボニルオキシ基、ハロゲン原子、又は、スクシンイミド-N-オキシ基を示し、Mは金属原子を示す。)
[25]
 R3が、メチル基であり、R4が、メチル基であり、R5とR6が、その結合する窒素原子とともに形成するイミダゾイル基である、或いは、R7が、アセトキシ基又はフッ素原子であり、Mがカリウム又はナトリウムである、[24]に記載の製造方法。
[26]
 溶媒が、N,N-ジメチルアセトアミドである、[24]又は[25]に記載の製造方法。
[27]
 塩基が、イミダゾールである、[24]-[26]のいずれか1項に記載の式(1)を有する化合物の製造方法。
[28]
 フロー合成による、[24]-[27]のいずれか1項に記載の製造方法。
(Wherein R 3 and R 4 are as defined above, and R 5 and R 6 are each independently a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or a substituted group. An aralkyl group which may be substituted, or R 5 and R 6 together with the nitrogen atom to which they are attached represent a heterocyclic group,
R 7 represents a C1-C6 alkylcarbonyloxy group, a halogen atom, or a succinimide-N-oxy group, and M represents a metal atom. )
[twenty five]
R 3 is a methyl group, R 4 is a methyl group, and R 5 and R 6 are imidazolyl groups formed together with the nitrogen atoms to which they are bonded, or R 7 is an acetoxy group or a fluorine atom. The production method according to [24], wherein M is potassium or sodium.
[26]
The production method according to [24] or [25], wherein the solvent is N, N-dimethylacetamide.
[27]
A method for producing a compound having the formula (1) according to any one of [24]-[26], wherein the base is imidazole.
[28]
The production method according to any one of [24]-[27] by flow synthesis.
[29]
 一般式(5)又は(5’)を有する化合物を用いて、加熱することによる、式(1)を有する化合物の製造方法。
[29]
A method for producing a compound having the formula (1) by heating using a compound having the general formula (5) or (5 ′).
Figure JPOXMLDOC01-appb-C000022

(式中、R3、R4、R5、R6、R7及びMは、上述と同義を示す。)
[30]
 [1]に記載の一般式(4)を有する化合物又はその塩基付加体を用いて、溶媒、塩基の存在下、式(1)を有する化合物を製造し、該式(1)を有する化合物を使用して、該式(1-6)を有する化合物を製造することによる、式(1-6)を有する化合物又はその塩の製造方法。
Figure JPOXMLDOC01-appb-C000022

(Wherein R 3 , R 4 , R 5 , R 6 , R 7 and M have the same meaning as described above.)
[30]
Using the compound having the general formula (4) described in [1] or a base adduct thereof, a compound having the formula (1) is produced in the presence of a solvent and a base, and the compound having the formula (1) is prepared. A method for producing a compound having the formula (1-6) or a salt thereof by using the compound having the formula (1-6).
Figure JPOXMLDOC01-appb-C000023

(式中、R3及びR4は、上述と同義を示す。)
Figure JPOXMLDOC01-appb-C000023

(Wherein R 3 and R 4 have the same meaning as described above.)
 本発明により、α2δリガンド作用が知られている化合物を製造する上での重要中間体を効率的かつ高品質で合成することができ、工業的にも大きなメリットを有する。 According to the present invention, an important intermediate for producing a compound known to have an α2δ ligand action can be synthesized efficiently and with high quality, which has a great industrial advantage.
(各置換基の説明等) (Description of each substituent, etc.)
Figure JPOXMLDOC01-appb-C000024
Figure JPOXMLDOC01-appb-C000024
一般式(4)を有する化合物に関する置換基R3及びR4
R3及びR4は、それぞれ独立して、水素原子、C1-C6アルキル基、置換されていてもよいアリール基、又は、置換されていてもよいアラルキル基を示し、又は、R3及びR4がそれらが結合する同一の炭素原子と一緒になって3-6員のシクロアルキル環を示す。
「C1-C6アルキル基」とは、炭素数1-6個の直鎖状または分岐鎖状アルキル基をいい、例えば、メチル基、エチル基、プロピル基、イソプロピル基、ブチル基、イソブチル基、sec-ブチル基、tert-ブチル基、ペンチル基、イソペンチル基、2-メチルブチル基、ネオペンチル基、1-エチルプロピル基、ヘキシル基、イソヘキシル基、4-メチルペンチル基、3-メチルペンチル基、2-メチルペンチル基、1-メチルペンチル基、3,3-ジメチルブチル基、2,2-ジメチルブチル基、1,1-ジメチルブチル基、1,2-ジメチルブチル基、1,3-ジメチルブチル基、2,3-ジメチルブチル基、2-エチルブチル基などがある。
 R3及びR4として、好適には、メチル基、エチル基、又は、プロピル基であり、より好適には、メチル基である、
「置換されていてもよいアリール基」とは、メチル基、エチル基等のC1-C6アルキル基、シアノ基、ニトロ基、ハロゲン原子等で1-3個置換されていてもよいフェニル基、メチル基、エチル基等のC1-C6アルキル基、シアノ基、ニトロ基、ハロゲン原子等で1-3個置換されていてもよいナフチル基等であり、好適には、フェニル基である。
「置換されていてもよいアラルキル基」とは、メチル基、エチル基等のC1-C6アルキル基、シアノ基、ニトロ基、ハロゲン原子等で1-3個置換されていてもよいベンジル基、メチル基、エチル基等のC1-C6アルキル基、シアノ基、ニトロ基、ハロゲン原子等で1-3個置換されていてもよいナフチルメチル基等であり、好適には、ベンジル基である。
「それらが結合する同一の炭素原子と一緒になって3-6員のシクロアルキル環」とは、シクロプロパン、シクロブタン、シクロペンタン、シクロヘキサンであり、それぞれの環は、C1-C6アルキル基、シアノ基、ニトロ基、ハロゲン原子等で1-3個置換されていてもよい。
「塩」とは、化合物が酸性基または塩基性基を有する場合に、塩基又は酸と反応させることにより、イオン対を形成したものにすることができるので、その塩を示す。
「塩基性塩」としては、好適には、ナトリウム塩、カリウム塩、リチウム塩のようなアルカリ金属塩;マグネシウム塩、カルシウム塩のようなアルカリ土類金属塩;N-メチルモルホリン塩、トリエチルアミン塩、トリブチルアミン塩、ジイソプロピルエチルアミン塩、ジシクロヘキシルアミン塩、N-メチルピペリジン塩、ピリジン塩、4-ピロリジノピリジン塩、ピコリン塩のような有機塩基塩類又はグリシン塩、リジン塩、アルギニン塩、オルニチン塩、グルタミン酸塩、アスパラギン酸塩のようなアミノ酸塩である。
Substituents R 3 and R 4 for compounds having general formula (4):
R 3 and R 4 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 3 and R 4 Together with the same carbon atom to which they are attached represent a 3-6 membered cycloalkyl ring.
"C1-C6 alkyl group" refers to a straight or branched alkyl group having 1 to 6 carbon atoms, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec -Butyl, tert-butyl, pentyl, isopentyl, 2-methylbutyl, neopentyl, 1-ethylpropyl, hexyl, isohexyl, 4-methylpentyl, 3-methylpentyl, 2-methyl Pentyl group, 1-methylpentyl group, 3,3-dimethylbutyl group, 2,2-dimethylbutyl group, 1,1-dimethylbutyl group, 1,2-dimethylbutyl group, 1,3-dimethylbutyl group, 2 , 3-dimethylbutyl group, 2-ethylbutyl group and the like.
R 3 and R 4 are preferably a methyl group, an ethyl group, or a propyl group, and more preferably a methyl group.
The “optionally substituted aryl group” means a C1-C6 alkyl group such as a methyl group or an ethyl group, a phenyl group which may be substituted with 1 to 3 groups such as a cyano group, a nitro group or a halogen atom, methyl Group, C1-C6 alkyl group such as ethyl group, cyano group, nitro group, naphthyl group optionally substituted by 1-3 halogen atoms, etc., preferably phenyl group.
The “optionally substituted aralkyl group” means a C1-C6 alkyl group such as a methyl group or an ethyl group, a benzyl group or a methyl group which may be substituted with a cyano group, a nitro group or a halogen atom. Group, a C1-C6 alkyl group such as an ethyl group, a cyano group, a nitro group, a naphthylmethyl group optionally substituted by 1-3 halogen atoms, and the like, and a benzyl group is preferred.
"3-6 membered cycloalkyl ring together with the same carbon atom to which they are attached" is cyclopropane, cyclobutane, cyclopentane, cyclohexane, each ring being a C1-C6 alkyl group, cyano 1-3 may be substituted with a group, a nitro group, a halogen atom or the like.
“Salt” refers to a salt of a compound having an acidic group or basic group, which can be formed into an ion pair by reacting with a base or acid.
The “basic salt” is preferably an alkali metal salt such as sodium salt, potassium salt or lithium salt; an alkaline earth metal salt such as magnesium salt or calcium salt; N-methylmorpholine salt, triethylamine salt, Organic base salts such as tributylamine salt, diisopropylethylamine salt, dicyclohexylamine salt, N-methylpiperidine salt, pyridine salt, 4-pyrrolidinopyridine salt, picoline salt or glycine salt, lysine salt, arginine salt, ornithine salt, glutamic acid Amino acid salts such as salt and aspartate.
「酸性塩」としては、好適には、フッ化水素酸塩、塩酸塩、臭化水素酸塩、ヨウ化水素酸塩のようなハロゲン化水素酸塩、硝酸塩、過塩素酸塩、硫酸塩、リン酸塩等の無機酸塩;メタンスルホン酸塩、トリフルオロメタンスルホン酸塩、エタンスルホン酸塩のような低級アルカンスルホン酸塩、ベンゼンスルホン酸塩、p-トルエンスルホン酸塩のようなアリ-ルスルホン酸塩、酢酸塩、リンゴ酸塩、フマ-ル酸塩、コハク酸塩、クエン酸塩、アスコルビン酸塩、酒石酸塩、蓚酸塩、マレイン酸塩等の有機酸塩;及び、グリシン塩、リジン塩、アルギニン塩、オルニチン塩、グルタミン酸塩、アスパラギン酸塩のようなアミノ酸塩である。 As the “acid salt”, preferably, hydrohalide such as hydrofluoride, hydrochloride, hydrobromide, hydroiodide, nitrate, perchlorate, sulfate, Inorganic acid salts such as phosphates; lower alkane sulfonates such as methane sulfonate, trifluoromethane sulfonate and ethane sulfonate, aryl sulfones such as benzene sulfonate and p-toluene sulfonate Acid salt, acetate salt, malate salt, fumarate salt, succinate salt, citrate salt, ascorbate salt, tartrate salt, succinate salt, maleate salt, etc .; and glycine salt, lysine salt , Amino acid salts such as arginine salt, ornithine salt, glutamate, aspartate.
本発明の化合物又はその薬理上許容される塩は、大気中に放置したり又は再結晶をすることにより、水分を吸収し、吸着水が付いたり、水和物となったりする場合があり、本発明には、そのような各種の水和物、溶媒和物及び結晶多形の化合物も包含する。 The compound of the present invention or a pharmacologically acceptable salt thereof may absorb moisture, adhere to adsorbed water, or become a hydrate when left in the air or by recrystallization. The present invention also includes such various hydrates, solvates and polymorphic compounds.
「塩基付加体」とは、化合物がルイス酸性基を有する場合に、適宜、ルイス塩基性化合物を反応させることにより、その付加した化合物を形成するので、それを塩基付加体と称する。ルイス塩基性化合物としては、例えば、酢酸カリウム、ピリジン、ジアザビシクロウンデセン(DBU)、トリエチルアミン、フッ化カリウム、1,2,4-トリアゾール、イミダゾール、ピラゾール、1,2,3-ベンゾトリアゾール、N-ヒドロキシスクシンイミド等を挙げることができる。これらのルイス塩基性化合物は、例えば、α,β-不飽和ジカルボニル化合物のような化合物と塩基付加体を形成し得る。3級アミンもルイス塩基性を有しており、付加することで自身は4級アンモニウムとなりながら、エノール型で酸素原子上にアニオンが立ち上がった形の分子内イオン対を有する塩基付加体を生成すると考えられる。 The “base adduct” is referred to as a base adduct because, when the compound has a Lewis acidic group, a Lewis basic compound is appropriately reacted to form the added compound. Examples of Lewis basic compounds include potassium acetate, pyridine, diazabicycloundecene (DBU), triethylamine, potassium fluoride, 1,2,4-triazole, imidazole, pyrazole, 1,2,3-benzotriazole, Examples thereof include N-hydroxysuccinimide. These Lewis basic compounds can form base adducts with compounds such as, for example, α, β-unsaturated dicarbonyl compounds. Tertiary amines also have Lewis basicity, and when they are added, they form quaternary ammoniums, but generate enol-type base adducts with intramolecular ion pairs in which anions are raised on oxygen atoms. Conceivable.
Figure JPOXMLDOC01-appb-C000025
Figure JPOXMLDOC01-appb-C000025
一般式(3)を有する化合物に関する置換基R1、R2及びX:
R1及びR2は、C1-C6アルキル基を示し、又は、R1及びR2が、それらが結合する同一の窒素原子と一緒になって4-6員飽和ヘテロシクリル基を示し、
Xはハロゲン原子を示す。
Substituents R 1 , R 2 and X for compounds having general formula (3):
R 1 and R 2 represent a C1-C6 alkyl group, or R 1 and R 2 together with the same nitrogen atom to which they are attached represent a 4-6 membered saturated heterocyclyl group,
X represents a halogen atom.
「C1-C6アルキル基」とは、上記と同義であり、R1及びR2として、好適には、エチル基、プロピル基、イソプロピル基、又は、イソブチル基であり、より好適には、イソブチル基である。
「それらが結合する同一の窒素原子と一緒になって4-6員飽和ヘテロシクリル基」とは、4-6員の飽和環状基であって、少なくとも炭素原子と一つの窒素原子を含有する飽和環状基であって、さらに、一つ以上の窒素原子、酸素原子又は硫黄原子を含有することがある飽和環状基であって、窒素原子上に結合手を有する基である。また、一般式(3)を有する化合物では、結合手を有する窒素原子は、イミニウムイオンとして存在している。
 本置換基として、少なくとも炭素原子と一つの窒素原子を含有する飽和環状基としては、アゼチジニル基、ピロリジニル基、ピペリジニル基等のイミニウムイオンであり、それぞれの基は、C1-C6アルキル基、シアノ基、ニトロ基、ハロゲン原子等で1-3個置換されていてもよい。好適には、ピペリジニル基のイミニウムイオンである。
 本置換基として、少なくとも炭素原子と一つの窒素原子を含有する飽和環状基であって、さらに、一つ以上の窒素原子、酸素原子又は硫黄原子を含有する飽和環状基としては、モルホリニル基、ピペラジニル基等のイミニウムイオンであり、それぞれの基は、C1-C6アルキル基、シアノ基、ニトロ基、ハロゲン原子等で1-3個置換されていてもよい。好適には、モルホリニル基のイミニウムイオンである。
The “C1-C6 alkyl group” has the same meaning as described above, and R 1 and R 2 are preferably an ethyl group, a propyl group, an isopropyl group, or an isobutyl group, and more preferably an isobutyl group. It is.
“A 4-6 membered saturated heterocyclyl group together with the same nitrogen atom to which they are attached” is a 4-6 membered saturated cyclic group containing at least a carbon atom and one nitrogen atom. A saturated cyclic group which may contain one or more nitrogen atoms, oxygen atoms or sulfur atoms, and has a bond on the nitrogen atom. In the compound having the general formula (3), the nitrogen atom having a bond is present as an iminium ion.
As the substituent, the saturated cyclic group containing at least a carbon atom and one nitrogen atom is an iminium ion such as an azetidinyl group, a pyrrolidinyl group, a piperidinyl group, and each group is a C1-C6 alkyl group, a cyano group. 1-3 may be substituted with a group, a nitro group, a halogen atom or the like. Preferred is an iminium ion of a piperidinyl group.
As this substituent, a saturated cyclic group containing at least a carbon atom and one nitrogen atom, and a saturated cyclic group containing one or more nitrogen atoms, oxygen atoms or sulfur atoms include morpholinyl group, piperazinyl An iminium ion such as a group, and each group may be substituted with 1-3 of C1-C6 alkyl group, cyano group, nitro group, halogen atom and the like. Preferably, it is an iminium ion of a morpholinyl group.
「ハロゲン原子」とは、フッ素原子、塩素原子、臭素原子又はヨウ素原子である。 The “halogen atom” is a fluorine atom, a chlorine atom, a bromine atom or an iodine atom.
Figure JPOXMLDOC01-appb-C000026
Figure JPOXMLDOC01-appb-C000026
一般式(5)又は(5’)を有する化合物に関する置換基R3、R4、R5、R6、R7及びM:
R3及びR4は、それぞれ独立して、水素原子、C1-C6アルキル基、置換されていてもよいアリール基、又は、置換されていてもよいアラルキル基を示し、又は、R3及びR4がそれらが結合する同一の炭素原子と一緒になって3-6員のシクロアルキル環を示し、
R5及びR6は、それぞれ独立して、水素原子、C1-C6アルキル基、置換されていてもよいアリール基を示し、又は、置換されていてもよいアラルキル基を示し、或いは、R5及びR6がそれらが結合する窒素原子と一緒になって複素環基を示し、
R7は、C1-C6アルキルカルボニルオキシ基、ハロゲン原子、又は、スクシンイミド-N-オキシ基を示し、
Mは金属原子を示す。
Substituents R 3 , R 4 , R 5 , R 6 , R 7 and M for compounds having general formula (5) or (5 ′):
R 3 and R 4 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 3 and R 4 Together with the same carbon atom to which they are attached represents a 3-6 membered cycloalkyl ring,
R 5 and R 6 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 5 and R 6 together with the nitrogen atom to which they are attached represents a heterocyclic group,
R 7 represents a C1-C6 alkylcarbonyloxy group, a halogen atom, or a succinimide-N-oxy group,
M represents a metal atom.
「C1-C6アルキル基」とは、上述と同義であるが、R3及びR4として好適な「C1-C6アルキル基」とは、メチル基である。
「置換されていてもよいアリール基」とは、上述と同義である。
「置換されていてもよいアラルキル基」とは、上述と同義である。
「それらが結合する同一の炭素原子と一緒になって3-6員のシクロアルキル環」とは、上述と同義である。
「それらが結合する窒素原子と一緒になって複素環基」とは、飽和又は不飽和の環状基であって、その環を形成する原子の一つ又は一つ以上に窒素原子、その他のヘテロ原子を含む環状基であって、複数の環状基が縮環している場合も含む。
具体的には以下に示すような基がある。
アジリジニル基、1H又は2Hアジリニル基、アゼチジニル基、ピロリジニル基、ピロリル基、イミダゾイル基、ピラゾイル基、オキサゾイル基、チアゾイル基、イミダゾリニル基、ピペリジニル基、モルホリニル基、ピペラジニル基、ピリジル基、テトラヒドロピリジル基、ピラジニル基、ピリミジニル基、チアジニル基、トリアゾイル基、インドイル基、イソインドイル基、ベンゾイミダゾイル基、ベンゾトリアゾイル基、キノリル基、イソキノリル基、キノキサリル基、テトラヒドロイソキノリル基、デカヒドロイソキノリル基、ジアザビシクロウンデセニル基、ジオキソピロリジニル基
好適には、イミダゾイル基、ピラゾイル基、ピリジル基、トリアゾイル基、ベンゾイミダゾイル基、ベンゾトリアゾイル基、ジアザビシクロウンデセニル基、ジオキソピロリジニル基等である。
The “C1-C6 alkyl group” has the same meaning as described above, but the “C1-C6 alkyl group” suitable as R 3 and R 4 is a methyl group.
The “optionally substituted aryl group” has the same meaning as described above.
The “optionally substituted aralkyl group” has the same meaning as described above.
“3-6 membered cycloalkyl ring together with the same carbon atom to which they are attached” is as defined above.
“Heterocyclic group together with the nitrogen atom to which they are attached” means a saturated or unsaturated cyclic group in which one or more of the atoms forming the ring are a nitrogen atom and other hetero groups It includes a cyclic group containing an atom, and a plurality of cyclic groups are condensed.
Specifically, there are groups as shown below.
Aziridinyl group, 1H or 2H azilinyl group, azetidinyl group, pyrrolidinyl group, pyrrolyl group, imidazolyl group, pyrazoyl group, oxazoyl group, thiazoyl group, imidazolinyl group, piperidinyl group, morpholinyl group, piperazinyl group, pyridyl group, tetrahydropyridyl group, pyrazinyl Group, pyrimidinyl group, thiazinyl group, triazoyl group, indoyl group, isoindoyl group, benzoimidazoloyl group, benzotriazoyl group, quinolyl group, isoquinolyl group, quinoxalyl group, tetrahydroisoquinolyl group, decahydroisoquinolyl group, dia Zabicycloundecenyl group, dioxopyrrolidinyl group, preferably imidazolyl group, pyrazoyl group, pyridyl group, triazoyl group, benzoimidazoloyl group, benzotriazoyl group, diazabicyclounde Group, a dioxopyrrolidinyl group.
「C1-C6アルキルカルボニルオキシ基」とは、C1-C6アルキル基にカルボニルオキシ基が結合した基であり、好適には、アセトキシ基である。
「ハロゲン原子」とは、上述と同義である。好適には、フッ素原子である。
「金属原子」とは、ナトリウム、カリウム、リチウムのようなアルカリ金属;マグネシウム、カルシウムのようなアルカリ土類金属であり、好適には、アルカリ金属である。
The “C1-C6 alkylcarbonyloxy group” is a group in which a carbonyloxy group is bonded to a C1-C6 alkyl group, and preferably an acetoxy group.
The “halogen atom” has the same meaning as described above. Preferable is a fluorine atom.
The “metal atom” is an alkali metal such as sodium, potassium or lithium; an alkaline earth metal such as magnesium or calcium, and preferably an alkali metal.
「メルドラム酸誘導体」とは、マロン酸と、種々のケトンから誘導されるR3及びR4が、それぞれ独立して、水素原子、C1-C6アルキル基、置換されていてもよいアリール基、又は、置換されていてもよいアラルキル基、又は、R3及びR4がそれらが結合する同一の炭素原子と一緒になって3-6員のシクロアルキル環となっている化合物である。 The “meldrum acid derivative” means that malonic acid and R 3 and R 4 derived from various ketones are each independently a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or , An optionally substituted aralkyl group, or a compound in which R 3 and R 4 together with the same carbon atom to which they are attached form a 3-6 membered cycloalkyl ring.
Figure JPOXMLDOC01-appb-C000027
Figure JPOXMLDOC01-appb-C000027
「フロー合成」とは、必要な原料、試薬等を溶液として温度調節したチューブリアクター等を通過させることによって、反応を行う方法である。 “Flow synthesis” is a method in which a reaction is performed by passing through a tube reactor or the like in which necessary raw materials, reagents and the like are adjusted in temperature as a solution.
(各製造工程の説明等)
 以下に、各製造工程について詳細に説明する。なお、本発明により、各工程をフロー合成で行うことによって、少量の溶媒で、少量の試薬で、短い反応時間で、高収率で反応を行うことができる。
(Description of each manufacturing process, etc.)
Below, each manufacturing process is demonstrated in detail. In addition, by performing each process by flow synthesis | combination by this invention, reaction can be performed with a small amount of solvent, a small amount of reagents, and a short reaction time with a high yield.
(1)
式(2)を有する化合物とメルドラム酸又はその誘導体との縮合反応により一般式(4)を有する化合物を製造する方法
(1)
Method for producing a compound having the general formula (4) by a condensation reaction between a compound having the formula (2) and Meldrum's acid or a derivative thereof
Figure JPOXMLDOC01-appb-C000028
Figure JPOXMLDOC01-appb-C000028
(式中の各記号は、上記と同様。)
 式(2)を有する化合物の溶液に、メルドラム酸又はその誘導体、塩基を添加した後、加熱することによって反応を行う。
 使用され得る溶媒:通常用いられる溶媒でよいが、好適には、N,N-ジメチルアセトアミド(DMAc)、トルエン等である。
 使用され得る塩基:通常用いられる塩基でよいが、好適には、モルホリン、N-エチルピペラジン、ピロリジン等である。
 反応温度は、通常、20-100℃である
 反応時間は、通常、10分から1時間である。
(Each symbol in the formula is the same as above.)
Meldrum acid or a derivative thereof, and a base are added to a solution of the compound having the formula (2), and then the reaction is performed by heating.
Solvents that can be used: Commonly used solvents may be used, but N, N-dimethylacetamide (DMAc), toluene and the like are preferable.
Bases that can be used: bases that are usually used may be used, but morpholine, N-ethylpiperazine, pyrrolidine and the like are preferable.
The reaction temperature is usually 20-100 ° C. The reaction time is usually 10 minutes to 1 hour.
 以下に、一般式(4)を有する化合物のフロー合成について説明する。 Hereinafter, the flow synthesis of the compound having the general formula (4) will be described.
Figure JPOXMLDOC01-appb-C000029
Figure JPOXMLDOC01-appb-C000029
式中の各記号は、上記と同様であり、その他スキーム中に使用されている記号は、以下の意義を有する。 Each symbol in the formula is the same as described above, and other symbols used in the scheme have the following significance.
Figure JPOXMLDOC01-appb-C000030
Figure JPOXMLDOC01-appb-C000030
:ポンプ(送液するためのもの) : Pump (for feeding liquid)
Figure JPOXMLDOC01-appb-C000031
Figure JPOXMLDOC01-appb-C000031
:ジョイント部(T字、溶液を混合させる部分) : Joint part (T-shape, part where solution is mixed)
Figure JPOXMLDOC01-appb-C000032
Figure JPOXMLDOC01-appb-C000032
:カラムリアクター(個体性の触媒や反応剤を詰めて反応させる) : Column reactor (reacts packed with individual catalyst and reactant)
Figure JPOXMLDOC01-appb-C000033
Figure JPOXMLDOC01-appb-C000033
:背圧弁(溶媒の沸点以上にするための圧力弁) : Back pressure valve (pressure valve to make it higher than the boiling point of the solvent)
Figure JPOXMLDOC01-appb-C000034
Figure JPOXMLDOC01-appb-C000034
:チューブリアクター(細い系を有するチューブもしくは金属管を巻きつけたもの。この中で実際の反応を実施する) : Tube reactor (A tube with a thin system or a metal tube wrapped around it. The actual reaction is carried out in this.)
Figure JPOXMLDOC01-appb-C000035
Figure JPOXMLDOC01-appb-C000035
:バッチポット(溶液を受けるポット) : Batch pot (pot for receiving solution)
Step A1
 Step A1は、カラムリアクター中で反応を行い、アルコールとアルデヒドからアセタールを生成させる工程である。
 このStepにおいては、試薬の等量は理論的に1等量で十分であるが、多くの通常の反応ではそれでは収率の向上が認められない。一方、フロー合成であれば、すべての試薬の当量が、1当量あるいは小過剰で十分に高い収率で得ることができる。例えば、ノルマルブチルアルデヒドに対して、各試薬を1当量あるいは小過剰使用することによって十分に高い収率で一般式(4)を有する化合物を得ることができる。
 反応に使用し得る溶媒は、溶媒を統一したほうがフロー合成にとっては効率的であり、その場合の溶媒として、テトラヒドロフランや1,2-ジメトキシエタンなどのエーテル系、並びにメタノール、エタノール、2-プロパノール等のアルコール系溶媒、トルエン等の炭化水素系溶媒、アセトニトリル等のニトリル系溶媒、並びに酢酸エチル等の脂肪族エステル系溶媒、あるいはN,N-ジメチルアセトアミドやN,N-ジメチルホルムアミド等のアミド系溶媒等が適しており、特に、アセトニトリルやN,N-ジメチルアセトアミド等の極性溶媒が好適である。当該Step A1においては、溶媒を用いなくても反応を円滑に行うことができる。
 反応温度は、-30℃から50℃の範囲がよく、さらに好適には-10℃から20℃の範囲で実施するのがよい。
 反応時間は、通常、5-30分である。
Step A1
Step A1 is a step in which a reaction is performed in a column reactor to produce acetal from alcohol and aldehyde.
In this step, the equivalent amount of reagent is theoretically equivalent to 1 equivalent, but in many ordinary reactions, no improvement in yield is observed. On the other hand, in the case of flow synthesis, the equivalents of all reagents can be obtained in a sufficiently high yield with one equivalent or a small excess. For example, the compound having the general formula (4) can be obtained in a sufficiently high yield by using one equivalent or a small excess of each reagent relative to normal butyraldehyde.
Solvents that can be used in the reaction are more efficient for flow synthesis when the solvents are unified. In such a case, ether solvents such as tetrahydrofuran and 1,2-dimethoxyethane, methanol, ethanol, 2-propanol, etc. Alcohol solvents such as toluene, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, aliphatic ester solvents such as ethyl acetate, or amide solvents such as N, N-dimethylacetamide and N, N-dimethylformamide In particular, polar solvents such as acetonitrile and N, N-dimethylacetamide are suitable. In Step A1, the reaction can be carried out smoothly without using a solvent.
The reaction temperature is preferably in the range of −30 ° C. to 50 ° C., more preferably in the range of −10 ° C. to 20 ° C.
The reaction time is usually 5-30 minutes.
Step A2
 Step A2は、Step A1で生成させたアセタールを、チューブリアクター内で酸及び酸無水物と反応させて式(2)を有する化合物を製造させる工程である。
 このStepにおいては、酸は0.3当量程度、酸無水物は2当量程度使用すればよい。
 反応に使用し得る溶媒は、Step A1と同様の溶媒である。
 当該Step A2においては、例えば、N,N-ジメチルアセトアミド(DMAc)のような溶媒を添加して、2mol/L程度の濃度で反応を行うことができる。
 反応温度は、120℃から300℃の範囲がよく、さらに好適には180℃から250℃の範囲で実施するのがよい。
 反応時間は、通常、10-40分である。
 チューブリアクターでは、背圧として、5bar程度の加圧が適当である。
Step A2
Step A2 is a step for producing the compound having the formula (2) by reacting the acetal produced in Step A1 with an acid and an acid anhydride in a tube reactor.
In this step, about 0.3 equivalents of acid and about 2 equivalents of acid anhydride may be used.
The solvent that can be used for the reaction is the same solvent as Step A1.
In Step A2, for example, a solvent such as N, N-dimethylacetamide (DMAc) can be added and the reaction can be performed at a concentration of about 2 mol / L.
The reaction temperature is preferably in the range of 120 ° C to 300 ° C, more preferably in the range of 180 ° C to 250 ° C.
The reaction time is usually 10-40 minutes.
In a tube reactor, a pressure of about 5 bar is appropriate as a back pressure.
Step A3
 Step A3は、Step A2で生成させた式(2)を有する化合物を、チューブリアクター内でメルドラム酸又はその誘導体と反応させて一般式(4)を有する化合物を製造させる工程である。
 このStepにおいても、メルドラム酸又はその誘導体は1当量程度使用すればよい。
 反応に使用し得る溶媒は、Step A1と同様の溶媒である。
 当該Step A3においては、例えば、N,N-ジメチルアセトアミド(DMAc)のような溶媒を添加して、2mol/L程度の濃度で反応を行うことができる。
 反応温度は、50℃から100℃の範囲がよく、さらに好適には60℃から80℃の範囲で実施するのがよい。
 反応時間は、通常、10-30分である。
Step A3
Step A3 is a step of producing a compound having the general formula (4) by reacting the compound having the formula (2) produced in Step A2 with Meldrum's acid or a derivative thereof in a tube reactor.
Also in this step, about 1 equivalent of Meldrum's acid or its derivative may be used.
The solvent that can be used for the reaction is the same solvent as Step A1.
In Step A3, for example, a solvent such as N, N-dimethylacetamide (DMAc) can be added and the reaction can be performed at a concentration of about 2 mol / L.
The reaction temperature is preferably in the range of 50 ° C to 100 ° C, more preferably 60 ° C to 80 ° C.
The reaction time is usually 10-30 minutes.
(2)
一般式(3)を有する化合物とメルドラム酸又はその誘導体との縮合反応により一般式(4)を有する化合物を製造する方法
(2)
Method for producing a compound having the general formula (4) by a condensation reaction between the compound having the general formula (3) and Meldrum's acid or a derivative thereof
Figure JPOXMLDOC01-appb-C000036
Figure JPOXMLDOC01-appb-C000036
(式中の各記号は、上記と同様。)
 一般式(3)を有する化合物の溶液に、メルドラム酸又はその誘導体、塩基を添加した後、加熱することによって反応を行う。
 使用され得る溶媒は、テトラヒドロフランや1,2-ジメトキシエタンなどのエーテル系、並びにメタノール、エタノール、2-プロパノール等のアルコール系溶媒、トルエン等の炭化水素系溶媒、アセトニトリル等のニトリル系溶媒、並びに酢酸エチル等の脂肪族エステル系溶媒、あるいはN,N-ジメチルアセトアミドやN,N-ジメチルホルムアミド等のアミド系溶媒等が適しており、特に、アセトニトリルやN,N-ジメチルアセトアミド等の極性溶媒が好適である。
 使用され得る塩基は、通常、用いられる塩基でよいが、好適には、モルホリンである。
 反応温度は、通常、20-40℃が好適である。
 反応時間は、通常、30分程度が好適である。
(Each symbol in the formula is the same as above.)
Meldrum acid or a derivative thereof, and a base are added to a solution of the compound having the general formula (3), and then the reaction is performed by heating.
Solvents that can be used include ether solvents such as tetrahydrofuran and 1,2-dimethoxyethane, alcohol solvents such as methanol, ethanol, and 2-propanol, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, and acetic acid. Aliphatic ester solvents such as ethyl or amide solvents such as N, N-dimethylacetamide and N, N-dimethylformamide are suitable, and polar solvents such as acetonitrile and N, N-dimethylacetamide are particularly suitable. It is.
The base that can be used is usually the base used, but is preferably morpholine.
The reaction temperature is usually preferably 20-40 ° C.
The reaction time is usually preferably about 30 minutes.
 以下に、一般式(4)を有する化合物のフロー合成について説明する。 Hereinafter, the flow synthesis of the compound having the general formula (4) will be described.
Figure JPOXMLDOC01-appb-C000037
Figure JPOXMLDOC01-appb-C000037
 スキーム中に使用されている記号は、上記と同様の意義を有する。 The symbols used in the scheme have the same significance as above.
Step B1
 Step B1は、カラムリアクター中で反応を行い、アミンとアルデヒドからエナミンを生成させる工程である。
 一般式(4)を有する化合物を合成する際に用いる試薬の等量は理論的に1当量で十分であるが、多くの通常の反応ではそれでは収率の向上が認められない。一方、フロー合成であれば、すべての試薬の当量が、1当量あるいは小過剰で十分に高い収率で得ることができる。例えば、ノルマルブチルアルデヒドに対して、各試薬を1当量あるいは小過剰使用することによって十分に高い収率で一般式(4)を有する化合物を得ることができる。
 反応に使用し得る溶媒は、溶媒を統一したほうがフロー合成にとっては効率的であり、その場合の溶媒として、テトラヒドロフランや1,2-ジメトキシエタンなどのエーテル系、並びにメタノール、エタノール、2-プロパノール等のアルコール系溶媒、トルエン等の炭化水素系溶媒、アセトニトリル等のニトリル系溶媒、並びに酢酸エチル等の脂肪族エステル系溶媒、あるいはN,N-ジメチルアセトアミドやN,N-ジメチルホルムアミド等のアミド系溶媒等が適しており、特に、アセトニトリルやN,N-ジメチルアセトアミド等の極性溶媒が好適である。当該Step B1においては、溶媒を用いなくても反応を円滑に行うことができる。
 反応温度は、-30℃から50℃の範囲がよく、さらに好適には室温近辺で実施するのがよい。
 反応時間は、通常、5-30分である。
 カラムリアクターでは、背圧として、40psi程度の加圧が適当である。
Step B1
Step B1 is a step in which enamine is produced from amine and aldehyde by performing reaction in a column reactor.
The equivalent amount of the reagent used in synthesizing the compound having the general formula (4) is theoretically equivalent to 1 equivalent, but in many usual reactions, no improvement in yield is observed. On the other hand, in the case of flow synthesis, the equivalents of all reagents can be obtained in a sufficiently high yield with one equivalent or a small excess. For example, the compound having the general formula (4) can be obtained in a sufficiently high yield by using one equivalent or a small excess of each reagent relative to normal butyraldehyde.
Solvents that can be used in the reaction are more efficient for flow synthesis when the solvents are unified. In such a case, ether solvents such as tetrahydrofuran and 1,2-dimethoxyethane, methanol, ethanol, 2-propanol, etc. Alcohol solvents such as toluene, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, aliphatic ester solvents such as ethyl acetate, or amide solvents such as N, N-dimethylacetamide and N, N-dimethylformamide In particular, polar solvents such as acetonitrile and N, N-dimethylacetamide are suitable. In Step B1, the reaction can be carried out smoothly without using a solvent.
The reaction temperature is preferably in the range of −30 ° C. to 50 ° C., and more preferably near room temperature.
The reaction time is usually 5-30 minutes.
In the column reactor, a pressure of about 40 psi is appropriate as the back pressure.
Step B2
 Step B2は、Step B1で生成させたエナミンを、チューブリアクター内でアリルハライドと反応させて一般式(3)を有する化合物を製造させる工程である。
 このStepにおいても、アリルハライドは1当量程度使用すればよい。
 反応に使用し得る溶媒は、Step B1と同様の溶媒である。
 当該Step B2においては、例えば、アセトニトリル(MeCN)もしくはN,N-ジメチルアセトアミド(DMAc)のような溶媒を添加して、2mol/L程度の濃度で反応を行うことができる。
 反応温度は、60℃から180℃の範囲がよく、さらに好適には100℃から150℃の範囲で実施するのがよい。
 反応時間は、通常、30-40分である。
 チューブリアクターでは、背圧として、100psi程度の加圧が適当である。
Step B2
Step B2 is a step in which the enamine produced in Step B1 is reacted with allyl halide in a tube reactor to produce a compound having the general formula (3).
Also in this step, about 1 equivalent of allyl halide may be used.
The solvent that can be used for the reaction is the same solvent as Step B1.
In Step B2, for example, a solvent such as acetonitrile (MeCN) or N, N-dimethylacetamide (DMAc) can be added and the reaction can be performed at a concentration of about 2 mol / L.
The reaction temperature is preferably in the range of 60 ° C to 180 ° C, more preferably in the range of 100 ° C to 150 ° C.
The reaction time is usually 30-40 minutes.
In a tube reactor, a pressure of about 100 psi is appropriate as a back pressure.
Step B3
 Step B3は、Step B2で生成させた一般式(3)を有する化合物を、チューブリアクター内でメルドラム酸又はその誘導体と反応させて一般式(4)を有する化合物を製造させる工程である。
 このStepにおいても、メルドラム酸又はその誘導体は1当量程度使用すればよい。
 反応に使用し得る溶媒は、Step B1と同様の溶媒である。
 当該Step B3においては、例えば、N,N-ジメチルアセトアミド(DMAc)のような溶媒を添加して、0.5mol/L程度の濃度で反応を行うことができる。
 反応温度は、50℃から100℃の範囲がよく、さらに好適には60℃から80℃の範囲で実施するのがよい。
 反応時間は、通常、10-15分である。
Step B3
Step B3 is a step of producing a compound having the general formula (4) by reacting the compound having the general formula (3) generated in Step B2 with Meldrum's acid or a derivative thereof in a tube reactor.
Also in this step, about 1 equivalent of Meldrum's acid or its derivative may be used.
The solvent that can be used for the reaction is the same solvent as Step B1.
In Step B3, for example, a solvent such as N, N-dimethylacetamide (DMAc) can be added and the reaction can be performed at a concentration of about 0.5 mol / L.
The reaction temperature is preferably in the range of 50 ° C to 100 ° C, more preferably 60 ° C to 80 ° C.
The reaction time is usually 10-15 minutes.
(3)
一般式(4)を有する化合物に、塩基を加えることによって、式(1)を有する化合物を製造する方法
(3)
Method for producing a compound having the formula (1) by adding a base to a compound having the general formula (4)
Figure JPOXMLDOC01-appb-C000038
Figure JPOXMLDOC01-appb-C000038
(式中の各記号は、上記と同様。)
 一般式(4)を有する化合物の溶液に、塩基を添加した後、加熱することによって式(1)を有する化合物を得る。
 使用され得る溶媒は、N,N-ジメチルアセトアミド(DMAc)、N,N-ジメチルホルムアミド(DMF)、N-メチルピロリドン(NMP)、ジグリム、スルホラン、キシレン、プロピレンカーボネート、ベンゾニトリル、シクロヘキサノン、クロロベンゼン、アニソール、ジブチルエーテル、酢酸ノルマルブチル、メチルイソブチルケトン、アセトフェノンであり、好適には、N,N-ジメチルアセトアミド(DMAc)である。
 使用され得る塩基は、好適には、酢酸カリウム、ピリジン、ジアザビシクロウンデセン(DBU)、トリエチルアミン、フッ化カリウム、1,2,4-トリアゾール、イミダゾール、ピラゾール、1,2,3-ベンゾトリアゾール、N-ヒドロキシスクシンイミドであり、より好適には、イミダゾールである。
 反応温度は、通常、120-220℃が好適であり、より好適には、120℃である。
 反応時間は、通常、10分から48時間が好適であり、より好適には、15時間である。
(Each symbol in the formula is the same as above.)
A compound having the formula (1) is obtained by adding a base to a solution of the compound having the general formula (4) and then heating.
Solvents that can be used are N, N-dimethylacetamide (DMAc), N, N-dimethylformamide (DMF), N-methylpyrrolidone (NMP), diglyme, sulfolane, xylene, propylene carbonate, benzonitrile, cyclohexanone, chlorobenzene, Anisole, dibutyl ether, normal butyl acetate, methyl isobutyl ketone and acetophenone are preferred, and N, N-dimethylacetamide (DMAc) is preferred.
Bases that can be used are preferably potassium acetate, pyridine, diazabicycloundecene (DBU), triethylamine, potassium fluoride, 1,2,4-triazole, imidazole, pyrazole, 1,2,3-benzotriazole N-hydroxysuccinimide, more preferably imidazole.
The reaction temperature is usually preferably 120-220 ° C, more preferably 120 ° C.
The reaction time is usually preferably 10 minutes to 48 hours, more preferably 15 hours.
 なお、本工程において、マイクロ波を使用するとともに、加熱を行うことによって反応時間を短縮することができる。
 使用し得るマイクロ波は、通常、5-150Wが好適であり、より好適には、150Wである。
In this step, the reaction time can be shortened by using microwaves and heating.
The microwave that can be used is usually preferably 5-150 W, and more preferably 150 W.
(4)
一般式(4)を有する化合物を加水分解して(及び一部脱炭酸して)、式(6)を有する化合物とした後、式(1)を有する化合物を製造する方法
(Four)
Method for producing a compound having the formula (1) after hydrolyzing (and partially decarboxylating) the compound having the general formula (4) to obtain a compound having the formula (6)
Figure JPOXMLDOC01-appb-C000039
 
Figure JPOXMLDOC01-appb-C000039
 
(式中の各記号は、上記と同様。)
Step4-1
 一般式(4)を有する化合物を加水分解して(及び一部脱炭酸して)、式(6)を有する化合物とする工程
 本工程では、水の存在下、溶媒として、N,N-ジメチルアセトアミド(DMAc)又はトルエンを使用して行う。
 本工程では、通常、反応温度は、160-180℃であり、反応時間は、5-10分である。
Step4-2
 式(6)を有する化合物(一部脱炭酸した化合物を含む)を加熱して、式(1)を有する化合物とする工程
 本工程では、無水酢酸及びトリエチルアミンの存在下、
 使用され得る溶媒:N,N-ジメチルアセトアミド(DMAc)、トルエン
 反応温度:120-180℃
 反応時間:30分-12時間
(Each symbol in the formula is the same as above.)
Step4-1
Step of hydrolyzing (and partially decarboxylating) a compound having the general formula (4) to form a compound having the formula (6) In this step, N, N-dimethyl is used as a solvent in the presence of water. Perform using acetamide (DMAc) or toluene.
In this step, the reaction temperature is usually 160-180 ° C., and the reaction time is 5-10 minutes.
Step4-2
A step of heating a compound having formula (6) (including a partially decarboxylated compound) to form a compound having formula (1). In this step, in the presence of acetic anhydride and triethylamine,
Solvents that can be used: N, N-dimethylacetamide (DMAc), toluene Reaction temperature: 120-180 ° C
Reaction time: 30 minutes-12 hours
(5)
一般式(4)を有する化合物に、塩基を加えることによって、一旦、一般式(5)又は(5’)を有する化合物を得た後、式(1)を有する化合物を製造する方法
(Five)
A method for producing a compound having the formula (1) after once obtaining a compound having the general formula (5) or (5 ′) by adding a base to the compound having the general formula (4)
Figure JPOXMLDOC01-appb-C000040
Figure JPOXMLDOC01-appb-C000040
(式中の各記号は、上記と同様。)
Step5-1:一般式(5)又は(5’)を有する化合物を得る工程
 使用され得る塩基:
 使用される塩基がアミンの場合、1級アミン、2級アミン、3級アミン等が考えられる。特に好適なものは、1級アミンではベンジルアミンのようなアミンが、また2級アミンではモルホリン、ピロリジン、ピペリジン、イミダゾール等であり、3級アミンでは、ジアザビシクロウンデセン(DBU)、と1,4-ジアザビシクロ[2.2.2]オクタン(DABCO)等である。
 使用される塩基が有機酸の塩基の場合には、C2-C6アルキルカルボン酸のアルカリ金属、又は、アルカリ土類金属の塩が好ましく、例えば、酢酸ナトリウム、酢酸カリウム等が挙げられる。
 使用される塩基が無機塩基の場合には、アルカリ金属、アルカリ土類金属を有する塩基でもよく、カルボン酸のアルカリ金属塩、あるいはアルカリ土類金属塩、またはアルコールのアルカリ金属塩あるいはアルカリ土類金属塩等がよい。
 使用される塩基の当量は、使用される塩基の種類によっても異なるが、通常、添加する塩基の当量は0.5当量から3当量の範囲がよく、特に0.9当量から1.5当量の範囲がよい。一般式(4)を有する化合物を合成する際に用いる試薬の当量は、理論的に1等量で十分であるが、多くの反応ではそれでは収率の向上が認められない。
 使用され得る溶媒は、テトラヒドロフランや1,2-ジメトキシエタンなどのエーテル系、並びにメタノール、エタノール、2-プロパノール等のアルコール系溶媒、トルエン等の炭化水素系溶媒、アセトニトリル等のニトリル系溶媒、並びに酢酸エチル等の脂肪族エステル系溶媒、あるいはN,N-ジメチルアセトアミドやN,N-ジメチルホルムアミド等のアミド系溶媒等が適しており、特に、アセトニトリルやN,N-ジメチルアセトアミド等の極性溶媒がよい。
 反応温度は、溶媒の沸点以内であればいずれの温度でも可能であり、室温付近で実施するのがよい。
 反応時間は、通常、5分から2時間が好適である。
(Each symbol in the formula is the same as above.)
Step 5-1: Step of obtaining a compound having the general formula (5) or (5 ′) Bases that can be used:
When the base used is an amine, primary amines, secondary amines, tertiary amines and the like are considered. Particularly suitable are amines such as benzylamine for primary amines, morpholine, pyrrolidine, piperidine, imidazole, etc. for secondary amines, and diazabicycloundecene (DBU) for tertiary amines and 1 , 4-diazabicyclo [2.2.2] octane (DABCO) and the like.
When the base used is an organic acid base, an alkali metal or alkaline earth metal salt of a C2-C6 alkyl carboxylic acid is preferable, and examples thereof include sodium acetate and potassium acetate.
When the base used is an inorganic base, it may be a base having an alkali metal or an alkaline earth metal, an alkali metal salt of a carboxylic acid, an alkaline earth metal salt, an alkali metal salt of an alcohol or an alkaline earth metal Salt is good.
The equivalent of the base to be used varies depending on the kind of the base to be used, but usually the equivalent of the base to be added is preferably in the range of 0.5 to 3 equivalents, particularly preferably in the range of 0.9 to 1.5 equivalents. The equivalent amount of the reagent used in the synthesis of the compound having the general formula (4) is theoretically equivalent to 1 equivalent, but in many reactions, no improvement in yield is observed.
Solvents that can be used include ether solvents such as tetrahydrofuran and 1,2-dimethoxyethane, alcohol solvents such as methanol, ethanol, and 2-propanol, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, and acetic acid. Aliphatic ester solvents such as ethyl or amide solvents such as N, N-dimethylacetamide and N, N-dimethylformamide are suitable, and polar solvents such as acetonitrile and N, N-dimethylacetamide are particularly good. .
The reaction temperature can be any temperature as long as it is within the boiling point of the solvent, and is preferably carried out at around room temperature.
The reaction time is usually preferably 5 minutes to 2 hours.
Step5-2:式(1)を有する化合物を得る工程
 使用され得る溶媒は、Step C1で使用され得るものと同様である。
 反応温度は、100℃から300℃の範囲であり、特に120℃から250℃の範囲がよい。
 反応時間は、通常、10分から48時間が好適である。
Step 5-2: Step of obtaining a compound having the formula (1) The solvents that can be used are the same as those that can be used in Step C1.
The reaction temperature is in the range of 100 ° C. to 300 ° C., and particularly preferably in the range of 120 ° C. to 250 ° C.
The reaction time is usually preferably 10 minutes to 48 hours.
 以下に、バッチ法及びフロー合成により、一般式(4)を有する化合物から一般式(5)又は(5’)を有する化合物を経由して、次いで、加熱を実施することにより式(1)を有する化合物を得る方法について説明する。 In the following, by the batch method and flow synthesis, the compound having the general formula (4) is passed through the compound having the general formula (5) or (5 ′), followed by heating to obtain the formula (1). A method for obtaining a compound having the above will be described.
Figure JPOXMLDOC01-appb-C000041
Figure JPOXMLDOC01-appb-C000041
(式中の各記号は、上記と同様。) (Each symbol in the formula is the same as above.)
Step C1
 Step C1は、一般式(4)を有する化合物を塩基と処理して、塩基付加体である一般式(5)を有する化合物を生成させる工程である。
 一般式(4)を有する化合物から塩基付加体を生成する際の塩基としては、すなわち一般式(5)を有する化合物を得るための塩基としては、通常のアルキルあるいはアラルキル基を有する1級アミン、芳香族1級アミン、またはアルキル基、アラアルキル基等を有する2級アミン、または芳香族2級アミン、さらにはアルキル基あるいはアラルキル基を有する3級アミン、または芳香族3級アミンがよい。ここで、塩基付加体とは、マイケル付加受容体と求核性を有するルイス塩基との反応付加体をいう。
 使用される塩基がアミンの場合、1級アミンではベンジルアミンのようなアミンが、また2級アミンではモルホリン、ピロリジン、ピペリジン、イミダゾール等がよい。
 使用される塩基が有機酸の塩基の場合には、C2-C6アルキルカルボン酸のアルカリ金属塩、又は、アルカリ土類金属塩が好ましく、例えば、酢酸ナトリウム、酢酸カリウム等が挙げられる。
 使用される塩基が無機塩基の場合には、マイケル付加し得るルイス塩基であればよく、アルカリ金属、アルカリ土類金属を有する塩基でもよく、例えば、フッ化カリウム等が挙げられる。
 使用される塩基の当量は、使用される塩基の種類によっても異なるが、通常、添加する塩基の当量は0.5当量から3当量の範囲がよく、特に0.9当量から1.5当量の範囲がよい。一般式(5)を有する化合物を合成する際に用いる試薬の当量は、理論的に1当量で十分であるが、多くの反応ではそれでは収率の向上が認められない。
 一方、フロー合成であれば、すべての試薬の当量が、1当量あるいは小過剰で十分に高い収率で一般式(5)を有する化合物を与えることができる。
 使用され得る溶媒は、テトラヒドロフランや1,2-ジメトキシエタンなどのエーテル系、並びにメタノール、エタノール、2-プロパノール等のアルコール系溶媒、トルエン等の炭化水素系溶媒、アセトニトリル等のニトリル系溶媒、並びに酢酸エチル等の脂肪族エステル系溶媒、あるいはN,N-ジメチルアセトアミドやN,N-ジメチルホルムアミド等のアミド系溶媒等が適しており、特に、アセトニトリルやN,N-ジメチルアセトアミド等の極性溶媒がよい。
 反応温度は、溶媒の沸点以内であればいずれの温度でも可能であり、室温付近で実施するのがよい。
 反応時間は、通常、5分から2時間程度である。
Step C1
Step C1 is a step of treating a compound having the general formula (4) with a base to produce a compound having the general formula (5) which is a base adduct.
As a base for producing a base adduct from a compound having the general formula (4), that is, as a base for obtaining a compound having the general formula (5), a primary amine having a normal alkyl or aralkyl group, An aromatic primary amine, a secondary amine having an alkyl group, an araalkyl group, or the like, or an aromatic secondary amine, further a tertiary amine having an alkyl group or an aralkyl group, or an aromatic tertiary amine is preferable. Here, the base adduct refers to a reaction adduct of a Michael addition acceptor with a nucleophilic Lewis base.
When the base used is an amine, an amine such as benzylamine is preferable for a primary amine, and morpholine, pyrrolidine, piperidine, imidazole, or the like is preferable for a secondary amine.
When the base used is an organic acid base, an alkali metal salt or alkaline earth metal salt of a C2-C6 alkylcarboxylic acid is preferable, and examples thereof include sodium acetate and potassium acetate.
When the base used is an inorganic base, it may be a Lewis base capable of Michael addition, and may be a base having an alkali metal or an alkaline earth metal, such as potassium fluoride.
The equivalent of the base to be used varies depending on the kind of the base to be used, but usually the equivalent of the base to be added is preferably in the range of 0.5 to 3 equivalents, particularly preferably in the range of 0.9 to 1.5 equivalents. The equivalent amount of the reagent used in synthesizing the compound having the general formula (5) is theoretically equivalent to 1 equivalent, but in many reactions, no improvement in yield is observed.
On the other hand, in the case of flow synthesis, the compound having the general formula (5) can be obtained in a sufficiently high yield with the equivalent amount of all reagents being one equivalent or a small excess.
Solvents that can be used include ethers such as tetrahydrofuran and 1,2-dimethoxyethane, alcohols such as methanol, ethanol and 2-propanol, hydrocarbons such as toluene, nitriles such as acetonitrile, and acetic acid. Aliphatic ester solvents such as ethyl or amide solvents such as N, N-dimethylacetamide and N, N-dimethylformamide are suitable, and polar solvents such as acetonitrile and N, N-dimethylacetamide are particularly good. .
The reaction temperature can be any temperature as long as it is within the boiling point of the solvent, and is preferably carried out at around room temperature.
The reaction time is usually about 5 minutes to 2 hours.
Step C2
 Step C2は、一般式(5)を有する化合物を加熱して、式(1)を有する化合物を生成させる工程である。
 使用され得る溶媒は、Step C1で使用され得るものと同様である。
 反応温度は、100℃から300℃の範囲であり、特に120℃から250℃の範囲がよい。
Step C2
Step C2 is a step of heating the compound having the general formula (5) to generate the compound having the formula (1).
Solvents that can be used are the same as those that can be used in Step C1.
The reaction temperature is in the range of 100 ° C. to 300 ° C., and particularly preferably in the range of 120 ° C. to 250 ° C.
Figure JPOXMLDOC01-appb-C000042
Figure JPOXMLDOC01-appb-C000042
 一般式(4)を有する化合物を加熱することのみで式(1)を有する化合物を得る場合、一般式(4)を有する化合物に加えるべき塩基としては、上述の塩基の中でも特にイミダゾール、酢酸ナトリウムあるいは酢酸カリウムがよい。
 一般式(4)を有する化合物を加熱することのみで式(1)を有する化合物を得る場合、溶媒としてはテトラヒドロフランや1,2-ジメトキシエタン、ジグリムなどのエーテル系、並びにメタノール、エタノール、2-プロパノール等のアルコール系溶媒、トルエン等の炭化水素系溶媒、アセトニトリル等のニトリル系溶媒、並びに酢酸エチル等の脂肪族エステル系溶媒、あるいはN,N-ジメチルアセトアミドやN,N-ジメチルホルムアミド等のアミド系溶媒等が適しており、特に、アセトニトリルやN,N-ジメチルアセトアミド等の極性溶媒ならびにジグリム等のエーテル系溶媒がよい。
When a compound having the formula (1) is obtained only by heating the compound having the general formula (4), the bases to be added to the compound having the general formula (4) include imidazole and sodium acetate among the above-mentioned bases. Or potassium acetate is good.
When the compound having the formula (1) is obtained only by heating the compound having the general formula (4), the solvent includes ethers such as tetrahydrofuran, 1,2-dimethoxyethane, diglyme, methanol, ethanol, 2- Alcohol solvents such as propanol, hydrocarbon solvents such as toluene, nitrile solvents such as acetonitrile, aliphatic ester solvents such as ethyl acetate, or amides such as N, N-dimethylacetamide and N, N-dimethylformamide Suitable solvents are, for example, polar solvents such as acetonitrile and N, N-dimethylacetamide, and ether solvents such as diglyme.
 一般式(4)を有する化合物を加熱することのみで式(1)を有する化合物を得る場合、反応温度は、100℃から300℃の範囲であり、特に120℃から250℃の範囲がよい。 When obtaining the compound having the formula (1) only by heating the compound having the general formula (4), the reaction temperature is in the range of 100 ° C. to 300 ° C., and particularly in the range of 120 ° C. to 250 ° C.
 以下、実施例および試験例を挙げて、本発明をさらに詳細に説明するが、本発明の範囲はこれらに限定されるものではない。 Hereinafter, the present invention will be described in more detail with reference to Examples and Test Examples, but the scope of the present invention is not limited thereto.
なお、実施例で用いる略号は、次のような意義を有する。
 DMAc:N,N-ジメチルアセトアミド
 MeCN:アセトニトリル
 MW:マイクロ波
 MP-TsOH:マクロ多孔質のポリスチレンスルホン酸
The abbreviations used in the examples have the following significance.
DMAc: N, N-dimethylacetamide MeCN: Acetonitrile MW: Microwave MP-TsOH: Macroporous polystyrene sulfonic acid
Figure JPOXMLDOC01-appb-C000043
Figure JPOXMLDOC01-appb-C000043
:サンプルループ(サンプル溶液を注入し、ポンプで押し出す) : Sample loop (Inject sample solution and push out with pump)
Figure JPOXMLDOC01-appb-C000044
Figure JPOXMLDOC01-appb-C000044
:FT-IR(測定機器、インラインにて実施) : FT-IR (Measurement equipment, implemented inline)
(製造例1)
(1,1-bis(allyloxy)butane)
アセタール法(フロー合成)
(Production Example 1)
(1,1-bis (allyloxy) butane)
Acetal method (flow synthesis)
Figure JPOXMLDOC01-appb-C000045
Figure JPOXMLDOC01-appb-C000045
 ブチルアルデヒド (75.1 g, 1.04 mol)とアリルアルコール (121.0 g, 2.08 mol)の混合液を調製し、MS3A (48.0 g)とMP-TsOH (24.0 g)の混合物を充填し、0 °Cに冷却したジャケット付きカラムリアクター (22mm id, 30cm)に混合液を2.4ml/minの流速で通した。30分間連続運転して得られた溶液には標記化合物が56.68g含まれていた (GC定量値、収率95%)。 Prepare a mixture of butyraldehyde (75.1 g, 1.04 mol) and allyl alcohol (121.0 g, 2.08 mol), fill with a mixture of MS3A (48.0 g) and MP-TsOH (24.0 g), and cool to 0 C The mixture was passed through a jacketed column reactor (22 mm id, 30 cm) at a flow rate of 2.4 ml / min. The solution obtained by continuous operation for 30 minutes contained 56.68 g of the title compound (GC quantitative value, yield 95%).
(製造例2)
2-ethylpent-4-enal(2)
化合物(2)(フロー合成)
(Production Example 2)
2-ethylpent-4-enal (2)
Compound (2) (flow synthesis)
Figure JPOXMLDOC01-appb-C000046
Figure JPOXMLDOC01-appb-C000046
 DMAc (60 mL)に対して1,1-bis(allyloxy)butane (20 g, 117.5 mmol)、Ac2O (24.0 g, 235.0 mmol)、Maleic acid (4.1 g, 35.2 mmol)を添加した。混合して完溶させた溶液を220 °Cに加熱したチューブリアクター (10 mL)に1.00 mL/minの流速で通した。1.5時間連続運転して得られた溶液には標記化合物が10.5 g含まれていた (GC定量値、収率89%)。 1,1-bis (allyloxy) butane (20 g, 117.5 mmol), Ac 2 O (24.0 g, 235.0 mmol) and Maleic acid (4.1 g, 35.2 mmol) were added to DMAc (60 mL). The mixed and completely dissolved solution was passed through a tube reactor (10 mL) heated to 220 ° C. at a flow rate of 1.00 mL / min. The solution obtained by continuous operation for 1.5 hours contained 10.5 g of the title compound (GC quantitative value, yield 89%).
(実施例1)
5-(2-Ethylpent-4-en-1-ylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione(4’)
(実施例1-1)
化合物(2)から化合物(4’)(バッチ反応)
(Example 1)
5- (2-Ethylpent-4-en-1-ylidene) -2,2-dimethyl-1,3-dioxane-4,6-dione (4 ')
(Example 1-1)
Compound (2) to Compound (4 ') (batch reaction)
Figure JPOXMLDOC01-appb-C000047
Figure JPOXMLDOC01-appb-C000047
 2-ethylpent-4-enal (0.89 g, 7.94 mmol)をDMAc(5.0mL)に溶解し、メルドラム酸 (1.42g, 9.85 mmol)、モルホリン (8μL, 0.09 mmol)を添加し、25 °Cで撹拌した。混合して完溶させた溶液を60 °Cで2時間撹拌した。得られた溶液には標記化合物がNMR定量値で1.5g(収率80%)で含まれていた。 2-ethylpent-4-enal (0.89 g, 7.94 mmol) is dissolved in DMAc (5.0mL), Meldrum's acid 1.4 (1.42g, 9.85 mmol), morpholine 8 (8μL, μ0.09 mmol) are added, and stirred at 25 、 C did. The completely dissolved solution was stirred at 60 ° C. for 2 hours. The resulting solution contained the title compound in an NMR quantitative value of 1.5 g (yield 80%).
(実施例1-2)
化合物(2)から化合物(4’)(フロー合成)
(Example 1-2)
Compound (2) to Compound (4 ') (Flow synthesis)
Figure JPOXMLDOC01-appb-C000048
Figure JPOXMLDOC01-appb-C000048
 2-ethylpent-4-enal (5.05 g, 45.0 mmol)が溶解した上記手法にて取得したDMAc溶液に対し、メルドラム酸 (7.14g, 49.5 mmol)、モルホリン (3.92 g, 45.0 mmol)を添加し、0 °Cで撹拌し溶解させた。混合して完溶させた溶液を70 °Cに加熱したチューブリアクター (10 mL)に0.33 mL/minの流速で通した。3時間連続運転して得られた溶液には標記化合物が8.90 g含まれていた (UPLC(登録商標)定量値、収率95%)。 To the DMAc solution obtained by the above method in which 2-ethylpent-4-enal (5.05 g, 45.0) mmol) was dissolved, Meldrum's (7.14 g, 49.5 mmol), morpholine (3.92 g, 45.0 mmol) were added, The mixture was stirred and dissolved at 0 ° C. The mixed and completely dissolved solution was passed through a tube reactor (10 mL) heated to 70 ° C at a flow rate of 0.33 mL / min. The solution obtained by continuous operation for 3 hours contained 8.90 g of the title compound (UPLC (registered trademark) quantitative value, yield 95%).
(実施例2)
5-(2-Ethylpent-4-en-1-ylidene)-2,2-dimethyl-1,3-dioxane-4,6-dione(4’)
エナミン法(3工程フロー連続化)
(Example 2)
5- (2-Ethylpent-4-en-1-ylidene) -2,2-dimethyl-1,3-dioxane-4,6-dione (4 ')
Enamine method (continuous 3 process flow)
Figure JPOXMLDOC01-appb-C000049
Figure JPOXMLDOC01-appb-C000049
 上記のようにフロー装置を設置した。Feed Aにジイソブチルアミン、Feed Bにブチルアルデヒド、Feed Cにアリルブロミド(24.20 g, 200 mmol)のDMAc溶液(計100mL, 2.0M)、Feed Dにメルドラム酸(14.41g, 100mmol)、モルホリン(875 μL, 10.0 mmol)のDMAc溶液 (計200 mL, メルドラム酸に対して0.5 M)を用意した。Feed Aを106 μL/min、Feed Bを55 μL/min、Feed Cを305 μL/min、Feed Dを1.20 mL/minでそれぞれ流し、図に示した通り、MS4A (30.00 g)を充填したカラムリアクター (15mm id, 30 cm)、120 °Cに加熱したチューブリアクター (16 mL)、60 °Cに加熱したチューブリアクター (10 mL×2)を通した。5時間連続運転して得られた溶液には標記化合物が26.79 g含まれていた (UPLC(登録商標)定量値、収率62%)。
1H NMR (CDCl3) (500 MHz): δ = 0.92 (3H, t, J = 7.5 Hz), 1.42-1.53 (1H, m), 1.62-1.72 (1H, m), 1.74 (s, 6H), 2.12-2.21 (1H, m), 2.33-2.42 (1H, m), 3.69-3.78 (1H, m), 4.97-5.06 (2H, m), 5.66-5.77 (1H, m), 7.63 (1H, d, J = 11.0 Hz).
13C NMR (CDCl3) (125 MHz): δ = 11.8, 27.3, 27.59, 27.60, 38.5, 41.1, 104.8, 117.2, 118.8, 135.1, 159.9, 161.9, 171.7.
The flow device was installed as described above. Feed A with diisobutylamine, Feed B with butyraldehyde, Feed C with DMAc solution of allyl bromide (24.20 g, 200 mmol) (100 mL, 2.0 M in total), Feed D with Meldrum acid (14.41 g, 100 mmol), morpholine (875 μL, 10.0 mmol) of DMAc solution (total 200 mL, 0.5 M against Meldrum's acid) was prepared. Feed A at 106 μL / min, Feed B at 55 μL / min, Feed C at 305 μL / min, Feed D at 1.20 mL / min, and a column packed with MS4A (30.00 g) as shown in the figure A reactor (15 mm id, 30 cm), a tube reactor heated to 120 ° C. (16 mL), and a tube reactor heated to 60 ° C. (10 mL × 2) were passed through. The solution obtained by continuous operation for 5 hours contained 26.79 g of the title compound (UPLC® quantitative value, yield 62%).
1 H NMR (CDCl 3 ) (500 MHz): δ = 0.92 (3H, t, J = 7.5 Hz), 1.42-1.53 (1H, m), 1.62-1.72 (1H, m), 1.74 (s, 6H) , 2.12-2.21 (1H, m), 2.33-2.42 (1H, m), 3.69-3.78 (1H, m), 4.97-5.06 (2H, m), 5.66-5.77 (1H, m), 7.63 (1H, d, J = 11.0 Hz).
13 C NMR (CDCl 3 ) (125 MHz): δ = 11.8, 27.3, 27.59, 27.60, 38.5, 41.1, 104.8, 117.2, 118.8, 135.1, 159.9, 161.9, 171.7.
(実施例3)
3-ethylbicyclo[3.2.0]hept-3-en-6-one(1)
(実施例3-1)
化合物(4’)から化合物(1)(バッチ反応)
(Example 3)
3-ethylbicyclo [3.2.0] hept-3-en-6-one (1)
(Example 3-1)
Compound (4 ') to Compound (1) (batch reaction)
Figure JPOXMLDOC01-appb-C000050
Figure JPOXMLDOC01-appb-C000050
 DMAc(1.0mL)に対し、室温にて化合物(4’)(200mg, 0.839mmol、含量86.1%)、イミダゾール(57.2mg, 0.840 mmol)を添加した後、120℃で15時間撹拌した。室温まで冷却後、MeCNと1M塩酸で希釈し、UPLC(登録商標)にて標記化合物を定量した(収量=49.10 mg、収率=56.6%)。 Compound (4 ') (200 mg, 0.839 mmol, content 86.1%) and imidazole (57.2 mg, 0.840 mmol) were added to DMAc (1.0 mL) at room temperature, followed by stirring at 120 ° C for 15 hours. After cooling to room temperature, it was diluted with MeCN and 1M hydrochloric acid, and the title compound was quantified with UPLC (registered trademark) (yield = 49.10 mg, yield = 56.6%).
(実施例3-2)
化合物(4’)から化合物(1)(マイクロ波反応装置)
(Example 3-2)
Compound (4 ') to Compound (1) (microwave reactor)
Figure JPOXMLDOC01-appb-C000051
Figure JPOXMLDOC01-appb-C000051
 DMAc(1.0mL)に対して窒素雰囲気下、室温にて化合物(4’)(100mg, 0.420mmol、含量86.1%)、イミダゾール(28.6mg, 0.420mmol)を添加した。続いて、マイクロ波反応装置(CEM社、Discover(登録商標))にて160℃(Max 150W)で10分間撹拌した後、室温まで冷却した。得られた反応液をMeCNと1M塩酸で希釈し、UPLC(登録商標)にて標記化合物を定量した(収量=38.74 mg、収率=81.2%)。 Compound (4 ') (100 mg, 0.420 mmol, 86.1% content) and imidazole (28.6 mg, 0.420 mmol) were added to DMAc (1.0 mL) at room temperature under a nitrogen atmosphere. Subsequently, the mixture was stirred for 10 minutes at 160 ° C. (Max 150 W) in a microwave reactor (CEM, Discover (registered trademark)), and then cooled to room temperature. The obtained reaction solution was diluted with MeCN and 1M hydrochloric acid, and the title compound was quantified with UPLC (registered trademark) (yield = 38.74 mg, yield = 81.2%).
(実施例3-3)
化合物(4’)から化合物(1)(フロー合成)
(Example 3-3)
Compound (4 ') to Compound (1) (flow synthesis)
Figure JPOXMLDOC01-appb-C000052
Figure JPOXMLDOC01-appb-C000052
 DMAc(1.0mL)に対し、化合物(4’)(200mg, 0.839mmol、含量86.1%))、イミダゾール(57.2mg, 0.840mmol)を添加し、室温にて撹拌した。得られた溶液(1.2mL)のうち1.0mL(166.6mg、0.699mmol相当)をサンプルループ(1.0mL)に導入し、200℃に加熱した10mlのチューブリアクターを500μL/minで通した(滞留時間20分)。続いて、反応液をMeCNと1M塩酸で希釈し、UPLC(登録商標)にて標記化合物(1)を定量した (収量=58.23 mg、収率=71.0%)。 Compound (4 ′) (200 mg, 0.839 mmol, content 86.1%)) and imidazole (57.2 mg, 0.840 mmol) were added to DMAc (1.0 mL), and the mixture was stirred at room temperature. 1.0 mL (equivalent to 166.6 mg, 0.699 mmol) of the obtained solution (1.2 mL) was introduced into the sample loop (1.0 mL), and passed through a 10 ml tube reactor heated to 200 ° C. at 500 μL / min (residence time). 20 min). Subsequently, the reaction solution was diluted with MeCN and 1M hydrochloric acid, and the title compound (1) was quantified with UPLC (registered trademark) (yield = 58.23 mg, yield = 71.0%).
(実施例4)
5-[2-ethyl-1-(1H-imidazol-1-yl)pent-4-en-1-yl]-2,2-dimethyl-1,3-dioxane-4,6-dione(5’)
化合物(4’)→化合物(5’’)
(Example 4)
5- [2-ethyl-1- (1H-imidazol-1-yl) pent-4-en-1-yl] -2,2-dimethyl-1,3-dioxane-4,6-dione (5 ')
Compound (4 ') → Compound (5'')
Figure JPOXMLDOC01-appb-C000053
Figure JPOXMLDOC01-appb-C000053
 化合物(4’)が溶解した、実施例1-2にて取得したDMAc溶液に対し、トルエン(5mL)、水(5 mL)、5%(w/w)重曹水(2mL)を添加し、分液した。水層についてはトルエン(2mL)で再抽出を行った。得られた有機層を合致し、5%(w/w)重曹水(2mL)で分液洗浄を2回繰り返した。
 その後、0.5規定塩酸水(2mL)で分液洗浄し、水(2mL)で分液した。得られた有機層をMeCNに溶媒置換し、窒素雰囲気下、室温にてイミダゾール(303mg, 4.45mmol)を添加した。室温下30分間撹拌後、室温下2時間撹拌した。結晶を濾過し、MeCN(3mL)で洗浄し、40℃で真空乾燥を行い、標記化合物を取得した(1.18g、収率91.5%)。
To the DMAc solution obtained in Example 1-2 in which the compound (4 ′) was dissolved, toluene (5 mL), water (5 mL), 5% (w / w) sodium bicarbonate water (2 mL) were added, Liquid separation was performed. The aqueous layer was re-extracted with toluene (2 mL). The obtained organic layers were matched, and liquid separation washing was repeated twice with 5% (w / w) sodium bicarbonate water (2 mL).
Thereafter, the mixture was washed with 0.5N hydrochloric acid (2 mL) and separated with water (2 mL). The obtained organic layer was substituted with MeCN, and imidazole (303 mg, 4.45 mmol) was added at room temperature under a nitrogen atmosphere. After stirring at room temperature for 30 minutes, the mixture was stirred at room temperature for 2 hours. The crystals were filtered, washed with MeCN (3 mL), and vacuum dried at 40 ° C. to obtain the title compound (1.18 g, yield 91.5%).
化合物(5’):
1H NMR (CD2Cl2, 500 MHz):δ = 0.92 (3H, t, J = 7.0 Hz), 1.42-1.53 (1H, m), 1.59-1.60 (1H, m), 1.62-1.70 (1H, m), 1.72 (s, 6H), 2.14-2.20 (1H, m), 2.35-2.40 (1H, m), 3.64-3.71 (1H, m), 4.88-5.16 (3H, m), 5.69-5.82 (1H, m), 7.10 (1H, m), 7.58 (1H, d, J = 11.5 Hz), 7.73 (1H, s).
Compound (5 '):
1 H NMR (CD 2 Cl 2 , 500 MHz): δ = 0.92 (3H, t, J = 7.0 Hz), 1.42-1.53 (1H, m), 1.59-1.60 (1H, m), 1.62-1.70 (1H , m), 1.72 (s, 6H), 2.14-2.20 (1H, m), 2.35-2.40 (1H, m), 3.64-3.71 (1H, m), 4.88-5.16 (3H, m), 5.69-5.82 (1H, m), 7.10 (1H, m), 7.58 (1H, d, J = 11.5 Hz), 7.73 (1H, s).
(実施例5)
3-ethylbicyclo[3.2.0]hept-3-en-6-one(1)
化合物(5’’)→化合物(1)
(Example 5)
3-ethylbicyclo [3.2.0] hept-3-en-6-one (1)
Compound (5 '') → Compound (1)
Figure JPOXMLDOC01-appb-C000054
Figure JPOXMLDOC01-appb-C000054
 DMAc (100 mL)に対し、化合物(5’’)(5.0 g, 16.3 mmol)を添加し、室温にて撹拌し溶解させた。得られた溶液(103.4 mL 97.5g)を200℃に加熱した10mlのチューブリアクターを500μL/minで通した(滞留時間20分)。続いて、反応液をMeCNで希釈し、UPLC(登録商標)にて標記化合物を定量した(収量=1.63g、収率=73.7%)。 Compound (5 ″) (5.0 g, 16.3 mmol) was added to DMAc (100 mL), and dissolved by stirring at room temperature. The resulting solution (103.4 mL 97.5 g) was passed through a 10 ml tube reactor heated to 200 ° C. at 500 μL / min (retention time 20 minutes). Subsequently, the reaction solution was diluted with MeCN, and the title compound was quantified with UPLC (registered trademark) (yield = 1.63 g, yield = 73.7%).

Claims (30)

  1.  一般式(4)を有する化合物又はその塩基付加体。
    Figure JPOXMLDOC01-appb-C000001
    (式中、R3及びR4は、それぞれ独立して、水素原子、C1-C6アルキル基、置換されていてもよいアリール基、又は、置換されていてもよいアラルキル基を示し、又は、R3及びR4がそれらが結合する同一の炭素原子と一緒になって3-6員のシクロアルキル環を示す。)
    A compound having the general formula (4) or a base adduct thereof.
    Figure JPOXMLDOC01-appb-C000001
    (Wherein R 3 and R 4 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or an optionally substituted aralkyl group, or R 3 and R 4 together with the same carbon atom to which they are attached represent a 3-6 membered cycloalkyl ring.)
  2.  請求項1に記載の一般式(4)を有する化合物。 A compound having the general formula (4) according to claim 1.
  3.  R3が、メチル基、エチル基、又は、プロピル基であり、R4が、メチル基、エチル基、又は、プロピル基である、請求項1に記載の一般式(4)を有する化合物又はその塩基付加体。 R 3 is a methyl group, an ethyl group, or a propyl group, and R 4 is a methyl group, an ethyl group, or a propyl group, or a compound having the general formula (4) according to claim 1, Base adduct.
  4.  R3が、メチル基であり、R4が、メチル基である、請求項1に記載の一般式(4)を有する化合物又はその塩基付加体。 2. The compound having the general formula (4) or a base adduct thereof according to claim 1, wherein R 3 is a methyl group and R 4 is a methyl group.
  5.  溶媒、塩基の存在下、式(2)を有する化合物と、メルドラム酸又はその誘導体を用いる請求項1に記載の一般式(4)を有する化合物又はその塩基付加体の製造方法。
    Figure JPOXMLDOC01-appb-C000002
    (式中、R3及びR4は、上述と同義を示す。)
    2. The process for producing a compound having the general formula (4) or a base adduct thereof according to claim 1, wherein the compound having the formula (2) and Meldrum's acid or a derivative thereof are used in the presence of a solvent and a base.
    Figure JPOXMLDOC01-appb-C000002
    (Wherein R 3 and R 4 have the same meaning as described above.)
  6.  R3が、メチル基、エチル基、又は、プロピル基であり、R4が、メチル基、エチル基、又は、プロピル基である、請求項5に記載の製造方法。 6. The production method according to claim 5, wherein R 3 is a methyl group, an ethyl group, or a propyl group, and R 4 is a methyl group, an ethyl group, or a propyl group.
  7.  R3が、メチル基であり、R4が、メチル基である、請求項5に記載の製造方法。 6. The production method according to claim 5, wherein R 3 is a methyl group and R 4 is a methyl group.
  8.  溶媒が、N,N-ジメチルアセトアミド又はトルエンであり、塩基が、モルホリン、N-メチルピペラジン、N-エチルピペラジン、ピペリジン、ピロリジンからなる群より選択されるいずれかである、請求項5-7のいずれか1項に記載の製造方法。 The solvent is N, N-dimethylacetamide or toluene, and the base is any one selected from the group consisting of morpholine, N-methylpiperazine, N-ethylpiperazine, piperidine, pyrrolidine. The production method according to any one of the above.
  9.  フロー合成による、請求項5-8のいずれか1項に記載の製造方法。 The manufacturing method according to any one of claims 5 to 8, which is performed by flow synthesis.
  10.  溶媒、塩基の存在下、一般式(3)を有する化合物と、メルドラム酸又はその誘導体を用いる請求項1に記載の一般式(4)を有する化合物又はその塩基付加体の製造方法。
    Figure JPOXMLDOC01-appb-C000003
    (式中、R1及びR2は、C1-C6アルキル基を示し、又は、R1及びR2が、それらが結合する同一の窒素原子と一緒になって4-6員飽和ヘテロシクリル基を示し、Xは、ハロゲン原子を示し、R3及びR4は、上述と同義を示す。)
    2. The process for producing a compound having the general formula (4) or a base adduct thereof according to claim 1, wherein the compound having the general formula (3) and Meldrum's acid or a derivative thereof are used in the presence of a solvent and a base.
    Figure JPOXMLDOC01-appb-C000003
    (Wherein R 1 and R 2 represent a C1-C6 alkyl group, or R 1 and R 2 together with the same nitrogen atom to which they are bonded represent a 4-6 membered saturated heterocyclyl group. X represents a halogen atom, and R 3 and R 4 have the same meaning as described above.)
  11.  R1が、エチル基、プロピル基、イソプロピル基、又は、イソブチル基であり、R2が、エチル基、プロピル基又は、イソプロピル基、又は、イソブチル基であり、又は、R1とR2が、同一の窒素原子に結合して、ピペリジン又はモルホリンであり、R3が、メチル基、エチル基、又は、プロピル基であり、R4が、メチル基、エチル基、又は、プロピル基である、請求項10に記載の製造方法。 R 1 is an ethyl group, a propyl group, an isopropyl group, or an isobutyl group, R 2 is an ethyl group, a propyl group, an isopropyl group, or an isobutyl group, or R 1 and R 2 are Bonded to the same nitrogen atom, piperidine or morpholine, R 3 is a methyl group, an ethyl group, or a propyl group, and R 4 is a methyl group, an ethyl group, or a propyl group, Item 11. The production method according to Item 10.
  12.  R1が、イソブチル基であり、R2が、イソブチル基であり、R3が、メチル基であり、R4が、メチル基である、請求項10に記載の製造方法。 11. The production method according to claim 10, wherein R 1 is an isobutyl group, R 2 is an isobutyl group, R 3 is a methyl group, and R 4 is a methyl group.
  13.  溶媒が、N,N-ジメチルアセトアミド又はアセトニトリルである、請求項10-12のいずれか1項に記載の製造方法。 The production method according to any one of claims 10 to 12, wherein the solvent is N, N-dimethylacetamide or acetonitrile.
  14.  塩基が、モルホリンである、請求項10-13のいずれか1項に記載の製造方法。 The production method according to any one of claims 10 to 13, wherein the base is morpholine.
  15.  フロー合成による、請求項10-14のいずれか1項に記載の製造方法。 The manufacturing method according to any one of claims 10 to 14, which is performed by flow synthesis.
  16.  溶媒、塩基の存在下、請求項1に記載の一般式(4)を有する化合物又はその塩基付加体を用いる式(1)を有する化合物の製造方法。
    Figure JPOXMLDOC01-appb-C000004
    (式中、R3及びR4は、上述と同義を示す。)
    A process for producing a compound having the formula (1) using the compound having the general formula (4) according to claim 1 or a base adduct thereof in the presence of a solvent and a base.
    Figure JPOXMLDOC01-appb-C000004
    (Wherein R 3 and R 4 have the same meaning as described above.)
  17.  R3が、メチル基、エチル基、又は、プロピル基であり、R4が、メチル基、エチル基、又は、プロピル基である、請求項16に記載の製造方法。 17. The production method according to claim 16, wherein R 3 is a methyl group, an ethyl group, or a propyl group, and R 4 is a methyl group, an ethyl group, or a propyl group.
  18.  R3が、メチル基であり、R4が、メチル基である、請求項16に記載の製造方法。 17. The production method according to claim 16, wherein R 3 is a methyl group and R 4 is a methyl group.
  19.  溶媒が、N,N-ジメチルアセトアミド(DMAc)、N,N-ジメチルホルムアミド(DMF)、N-メチルピロリドン(NMP)、ジグリム、スルホラン、キシレン、プロピレンカーボネート、ベンゾニトリル、シクロヘキサノン、クロロベンゼン、アニソール、ジブチルエーテル、酢酸ノルマルブチル、メチルイソブチルケトン、アセトフェノンからなる群より選択されるいずれか1種又は2種以上である、請求項16-18のいずれか1項に記載の製造方法。 Solvent is N, N-dimethylacetamide (DMAc), N, N-dimethylformamide (DMF), N-methylpyrrolidone (NMP), diglyme, sulfolane, xylene, propylene carbonate, benzonitrile, cyclohexanone, chlorobenzene, anisole, di- The production method according to any one of claims 16 to 18, wherein the production method is one or more selected from the group consisting of butyl ether, normal butyl acetate, methyl isobutyl ketone, and acetophenone.
  20.  塩基が、酢酸カリウム、ピリジン、ジアザビシクロウンデセン(DBU)、トリエチルアミン、フッ化カリウム、1,2,4-トリアゾール、イミダゾール、ピラゾール、1,2,3-ベンゾトリアゾール、N-ヒドロキシスクシンイミドからなる群より選択されるいずれか1種である、請求項16-19のいずれか1項に記載の製造方法。 Base consists of potassium acetate, pyridine, diazabicycloundecene (DBU), triethylamine, potassium fluoride, 1,2,4-triazole, imidazole, pyrazole, 1,2,3-benzotriazole, N-hydroxysuccinimide The production method according to any one of claims 16 to 19, which is any one selected from the group.
  21.  フロー合成による、請求項16-20のいずれか1項に記載の製造方法。 The manufacturing method according to any one of claims 16 to 20, which is performed by flow synthesis.
  22.  請求項1に記載の一般式(4)を有する化合物又はその塩基付加体を用いて、加水分解により一般式(6)を有する化合物又はその塩を得る工程を経る、式(1)を有する化合物の製造方法。
    Figure JPOXMLDOC01-appb-C000005
    (式中、R3及びR4は、上述と同義を示す。)
    A compound having the formula (1) which undergoes a step of obtaining a compound having the general formula (6) or a salt thereof by hydrolysis using the compound having the general formula (4) according to claim 1 or a base adduct thereof. Manufacturing method.
    Figure JPOXMLDOC01-appb-C000005
    (Wherein R 3 and R 4 have the same meaning as described above.)
  23.  フロー合成による、請求項22に記載の製造方法。 23. The manufacturing method according to claim 22, which is performed by flow synthesis.
  24.  溶媒、塩基の存在下、請求項1に記載の一般式(4)を有する化合物を用いて、一般式(5)又は(5’)を有する化合物を得た後、加熱することによる、式(1)を有する化合物の製造方法。
    Figure JPOXMLDOC01-appb-C000006
    (式中、R3及びR4は、上述と同義を示し、R5及びR6は、それぞれ独立して、水素原子、C1-C6アルキル基、置換されていてもよいアリール基を示し、又は、置換されていてもよいアラルキル基を示し、或いは、R5及びR6がそれらが結合する窒素原子と一緒になって複素環基を示し、R7は、C1-C6アルキルカルボニルオキシ基、ハロゲン原子、又は、スクシンイミド-N-オキシ基を示し、Mは金属原子を示す。)
    Using the compound having the general formula (4) according to claim 1 in the presence of a solvent or a base, the compound having the general formula (5) or (5 ′) is obtained, and then heated to obtain the formula ( A method for producing a compound having 1).
    Figure JPOXMLDOC01-appb-C000006
    (Wherein R 3 and R 4 are as defined above, and R 5 and R 6 each independently represent a hydrogen atom, a C1-C6 alkyl group, an optionally substituted aryl group, or Represents an optionally substituted aralkyl group, or R 5 and R 6 together with the nitrogen atom to which they are bonded represent a heterocyclic group, R 7 represents a C1-C6 alkylcarbonyloxy group, halogen An atom or a succinimide-N-oxy group, and M represents a metal atom.)
  25.  R3が、メチル基であり、R4が、メチル基であり、R5とR6がそれらが結合する窒素原子とともに形成するイミダゾイル基である、或いは、R7が、アセトキシ基又はフッ素原子であり、Mがカリウム又はナトリウムである、請求項24に記載の製造方法。 R 3 is a methyl group, R 4 is a methyl group, and R 5 and R 6 are imidazolyl groups formed together with the nitrogen atom to which they are bonded, or R 7 is an acetoxy group or a fluorine atom. 25. The production method according to claim 24, wherein M is potassium or sodium.
  26.  溶媒が、N,N-ジメチルアセトアミドである、請求項24又は25に記載の製造方法。 26. The production method according to claim 24 or 25, wherein the solvent is N, N-dimethylacetamide.
  27.  塩基が、イミダゾールである、請求項24-26のいずれか1項に記載の式(1)を有する化合物の製造方法。 27. The method for producing a compound having the formula (1) according to any one of claims 24-26, wherein the base is imidazole.
  28.  フロー合成による、請求項24-27のいずれか1項に記載の製造方法。 28. The production method according to any one of claims 24-27, which is performed by flow synthesis.
  29.  一般式(5)又は(5’)を有する化合物を用いて、加熱することによる、式(1)を有する化合物の製造方法。
    Figure JPOXMLDOC01-appb-C000007
    (式中、R3、R4、R5、R6、R7及びMは、上述と同義を示す。)
    A method for producing a compound having the formula (1) by heating using a compound having the general formula (5) or (5 ′).
    Figure JPOXMLDOC01-appb-C000007
    (Wherein R 3 , R 4 , R 5 , R 6 , R 7 and M have the same meaning as described above.)
  30.  請求項1に記載の一般式(4)を有する化合物又はその塩基付加体を用いて、溶媒、塩基の存在下、式(1)を有する化合物を製造し、該式(1)を有する化合物を使用して、該式(1-6)を有する化合物を製造することによる、式(1-6)を有する化合物又はその塩の製造方法。
    Figure JPOXMLDOC01-appb-C000008
    (式中、R3及びR4は、上述と同義を示す。)
    A compound having the formula (1) is produced using the compound having the general formula (4) according to claim 1 or a base adduct thereof in the presence of a solvent and a base, and the compound having the formula (1) A method for producing a compound having the formula (1-6) or a salt thereof by using the compound having the formula (1-6).
    Figure JPOXMLDOC01-appb-C000008
    (Wherein R 3 and R 4 have the same meaning as described above.)
PCT/JP2017/015019 2016-04-18 2017-04-12 Method for producing bicyclic compound using meldrum's acid WO2017183539A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2016082755 2016-04-18
JP2016-082755 2016-04-18

Publications (1)

Publication Number Publication Date
WO2017183539A1 true WO2017183539A1 (en) 2017-10-26

Family

ID=60116817

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2017/015019 WO2017183539A1 (en) 2016-04-18 2017-04-12 Method for producing bicyclic compound using meldrum's acid

Country Status (1)

Country Link
WO (1) WO2017183539A1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009041453A1 (en) * 2007-09-28 2009-04-02 Daiichi Sankyo Company, Limited Bicyclic γ-amino acid derivative
WO2010070593A2 (en) * 2008-12-19 2010-06-24 Pfizer Ireland Pharmaceuticals Malonate esters
WO2012169475A1 (en) * 2011-06-08 2012-12-13 第一三共株式会社 Method for producing bicyclic compound via claisen rearrangement
WO2012169474A1 (en) * 2011-06-08 2012-12-13 第一三共株式会社 Method for producing bicyclic compound via iminium salt

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009041453A1 (en) * 2007-09-28 2009-04-02 Daiichi Sankyo Company, Limited Bicyclic γ-amino acid derivative
WO2010070593A2 (en) * 2008-12-19 2010-06-24 Pfizer Ireland Pharmaceuticals Malonate esters
WO2012169475A1 (en) * 2011-06-08 2012-12-13 第一三共株式会社 Method for producing bicyclic compound via claisen rearrangement
WO2012169474A1 (en) * 2011-06-08 2012-12-13 第一三共株式会社 Method for producing bicyclic compound via iminium salt

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DAVIDSON, DAVID ET AL.: "The Structure of Meldrum's supposed beta-lactonic acid", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, vol. 70, no. 10, 1948, pages 3426 - 3428, XP055602100, ISSN: 0002-7863, DOI: 10.1021/ja01190a060 *
LARCHEVEQUE, MARC ET AL.: "Diastereoselective Synthesis of Enantiomerically Pure syn- or anti- beta -Alkyl y -Alkoxyesters by Addition of Organometallic Compounds to alpha-Alkoxy Isopropylidene Alkylidenemalonates", JOURNAL OF THE CHEMICAL SOCIETY, CHEMICAL COMMUNICATIONS, vol. 1989, no. 1, pages 31 - 33, XP000994922, ISSN: 0022-4936, DOI: doi:10.1039/c39890000031 *
PATTENDEN, GERALD ET AL.: "Transannular cyclisation as a stratagem in synthesis. A total synthesis of (±)-pentalenene", TETRAHEDRON, vol. 43, no. 23, 1987, pages 5637 - 5652, XP055602092, ISSN: 0040-4020 *

Similar Documents

Publication Publication Date Title
JP5642067B2 (en) Process for preparing derivatives of 1- (2-halobiphenyl-4-yl) -cyclopropanecarboxylic acid
JPH04334375A (en) Preparation of malonic anhydride
JP7357621B2 (en) Novel processes and intermediates for preparing soluble guanylyl cyclase stimulators
Mahmud et al. An intramolecular azomethine ylide–alkene cycloaddition approach to pyrrolo [3, 2-c] quinolines-synthesis of a C2-truncated martinelline model
JP5476305B2 (en) Method for producing bicyclo [2.2.2] octylamine derivative
TWI812679B (en) Process for preparing soluble guanylate cyclase stimulators
WO2017183539A1 (en) Method for producing bicyclic compound using meldrum's acid
US8742162B2 (en) Method for producing optically active 1-amino-2-vinylcyclopropanecarboxylic acid ester
TWI314932B (en) New synthesis of a camptothecin subunit
Coe et al. Preparation and reactions of 2, 3, 4, 6-tetrafluoropyridine and its derivatives
JP4899385B2 (en) Method for producing 3-aminomethyloxetane compound
WO2006129781A1 (en) Process for production of dibenzoxepin derivative
JP6289177B2 (en) Method for producing nitrogen-containing heterocyclic compound
WO2014126244A1 (en) Method for producing amino acid and amino acid synthesis kit
CN112239423B (en) Synthetic method of alpha-arylated amide compound
CN110903245B (en) Key intermediate for synthesizing 1-alkyl-2-trifluoromethyl-5-amino-1H-imidazole and preparation method thereof
JPH07291933A (en) Production of 2,5-disubstituted pyridine
CN110759923B (en) Pyrimidopyrrolopyridazine derivatives, intermediates thereof, preparation method, pharmaceutical compositions and uses
US7265238B2 (en) Process for preparing methyl 4-(aminomethyl)benzoate
JP5309680B2 (en) Method for producing fluorinated ester compound and intermediate thereof
JPWO2016190280A1 (en) Process for producing O- [1- (2-hydroxypropyl)] oxime compound
Herter et al. Preparation of 3, 5-methanobenzo [b] azepines: a novel sp3-rich Quinolone Isostere.
JP2024509995A (en) Method for preparing risdiplam
CN117567419A (en) Synthesis method of 3-amine methyl primary ketone derivative
CN118580159A (en) Synthesis method of nitrogen heterocyclic aromatic hydrocarbon modified beta-amino acid ester

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 17785878

Country of ref document: EP

Kind code of ref document: A1

122 Ep: pct application non-entry in european phase

Ref document number: 17785878

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: JP